Endocrine Abstracts

Contents

• Plenary Lecturers’ Biographical Notes
• • European Journal of Endocrinology Prize Lecture
  • • European Journal of Endocrinology Abstract

      ea0011s1
  • Geoffrey Harris Prize Lecture
  • • A tale of modern endocrinology

      ea0011s2
  • Transatlantic Medal Lecture
  • • Nuclear receptors and transcriptional control of lipid metabolism

      ea0011s3
  • Clinical Endocrinology Trust Visiting Professor Lecture
  • • Understanding the genetic control of puberty in the human

      ea0011s4
  • British Thyroid Association Pitt-Rivers Lecture
  • • Neurological abnormalities in mice with a dominant negative thyroid hormone alpha 1

      ea0011s5
  • Society for Endocrinology Dale Medal Lecture
  • • The actions of inhibin in endocrine tissues

      ea0011s6
  • Clinical Endocrinology Trust Lecture
  • • Thyroid disease paradigms and problems

      ea0011s7
  • Vitamin D action
  • • Vitamin D action

      ea0011s8
  • Psychological determinants of metabolic risk
  • • Rhabdomyolysis and other adverse effects of statins: what happens when we inhibit HMG CoA reductase

      ea0011s9
  • Embryonic stem cells
  • • Stem cells: regeneration in type 1 diabetes

      ea0011s10
• Symposia
• • Thyroid and the heart
  • • Cardiac repercussions of thyroid hormones

      ea0011s11
    • The assessment of cardiovascular risk factors in thyroid disease

      ea0011s12
    • Iodothyronamines: rapid-acting thyroid hormone metabolites

      ea0011s13
    • Role of thyroid hormone receptor isoforms in development and function of heart and other tissues

      ea0011s14
  • The endocrinology of psychiatric disease
  • • Glucocorticoids, enzymes and memory impairments with ageing

      ea0011s15
    • Effects of hypothyroidism on brain metabolism and its associations with neuropsychiatric impairments

      ea0011s16
    • Overview of neuroendocrine side-effects

      ea0011s17
    • Endocrinology of post traumatic stress

      ea0011s18
  • Cancer and the skeleton
  • • Mechanisms of malignant hypercalcaemia

      ea0011s19
    • Hypercalcaemia of malignancy

      ea0011s20
    • Oncogenic osteomalacia: novel insights into the regulation of phosphate homeostasis

      ea0011s21
    • Why does thyroid carcinoma metastasise to bone?

      ea0011s22
  • Cannabinoid signalling
  • • Cannabinoids as modulators of neuroendocrine signaling

      ea0011s23
    • Cannabinoids and feeding behaviour

      ea0011s24
    • ea0011s25
  • Novel peptides in reproduction
  • • The Kisspeptin-GPR54 axis in reproduction

      ea0011s26
    • Use of recombinant leptin in women with hypothalamic amenorrhea

      ea0011s27
    • A genomic analysis of polypeptide ligands and receptors: the example of relaxin and LGR families

      ea0011s28
    • Novel recombinant gonadotropin molecules in human reproductive dysfunction

      ea0011s29
  • Flies, worms and fish: use in endocrine research
  • • ea0011s30
    • Dietary restriction and altered insulin/Igf1 signalling: conserved mechanisms regulating lifespan in worms, flies and rodents

      ea0011s31
    • Giant flies and more: probing the functions and genetics of insulin signalling in Drosophila

      ea0011s32
    • Specifying the cellular responses to IGF signalling by IGF binding proteins: new lessons from the zebrafish model

      ea0011s33
  • Clinical lessons from novel aspects of G protein-coupled receptors signalling
  • • How the pattern of GPCR co-expression can regulate function

      ea0011s34
    • Alpha- and beta-adrenoceptor dysfunction

      ea0011s35
    • Moleular pathology of the FSH receptor

      ea0011s36
    • Therapeutic implications from new aspects in V2 vasopressin receptor dysfunction

      ea0011s37
  • Stromal cell-matrix interactions
  • • Role of heparan sulphates in neuronal stem cell differentiation

      ea0011s38
    • Hormonal regulation of mesenchymal stem cell differentiation in bone

      ea0011s39
    • Cell-adhesion molecules and osteoclast function

      ea0011s40
    • Wnt signalling in the stem cell niche

      ea0011s41
  • Controversies in male health
  • • Does andropause exist?

      ea0011s42
    • Cardiovascular effects of androgens

      ea0011s43
    • Endocrine regulation of prostatic growth

      ea0011s44
    • Stem cell therapeutic approaches to male infertility

      ea0011s45
  • How hormones get into cells
  • • Specific thyroid hormone transporters

      ea0011s46
    • The spectrum of MCT8 gene mutations

      ea0011s47
    • Multidrug resistance P-glycoprotein (mdr-1) excluding corticosteroids from brain

      ea0011s48
    • Cell surface carrier - mediated transport of steroid hormones

      ea0011s49
  • Endocrinology in the foetus
  • • Maternal thyroid function and cognitive impairment in childhood

      ea0011s50
    • Molecular basis of programming of renin-secreting cells

      ea0011s51
    • Birth weight and later disease: genes and maternal diabetes

      ea0011s52
    • Endocrine therapy of the fetus

      ea0011s53
  • Monogenic disorders illuminate metabolic disease
  • • Epidemic obesity in humans

      ea0011s54
    • Specific metabolic features in Prader-Labhart-Willi syndome (PWS) as indicators of the underlying genetic defect

      ea0011s55
    • PPAR gamma and human metabolic disease

      ea0011s56
    • Learning from monogenic diabetes: insights into the fetal and adult beta-cell

      ea0011s57
  • Steroid hormone receptors
  • • The ups and downs of nuclear receptor action in fat and fertility

      ea0011s58
    • Chromatin remodeling

      ea0011s59
    • Cell membrane receptors of steroid hormones

      ea0011s60
    • Lysine modifications in transcriptional regulation by steroid receptors

      ea0011s61
  • Anabolic hormones in sport
  • • Overview of anabolic steroids in sport

      ea0011s62
    • Detecting growth hormone abuse in athletes

      ea0011s63
    • Gene doping: will the age of gene therapy usher in the age of genetic enhancement?

      ea0011s64
    • Erythropoietin

      ea0011s65
  • Disorders of melanocortin receptor functions
  • • MC1R variants: Mendle is quite complex enough

      ea0011s66
    • Identification of the genes causing ACTH insensitivity

      ea0011s67
    • Melanocortin receptor mutations in humans

      ea0011s68
    • Gs-independent signalling of melanocortin-4 receptors

      ea0011s69
  • Endocrine oncogenesis and management of hereditary endocrine tumours
  • • RET function and dysfunction

      ea0011s70
    • Novel management strategies in medullary carcinoma of the thyroid

      ea0011s71
    • Hypoxia inducible factor (HIF) and phaeochromocytoma

      ea0011s72
    • Familial phaeochromocytomas

      ea0011s73
  • Green over-the-counter endocrinology
  • • ea0011s74
    • Regulation of steroid receptor expression and proliferation in prostate cancer by genistein and other flavonoids

      ea0011s75
    • Soy, flavonoids and osteoporosis

      ea0011s76
    • Aftermath of WHI: the risks or benefits of red clover and soy extracts in postmenopausal OTC HRT

      ea0011s77
  • Management of complex genital anomalies and the transition from childhood to adulthood
  • • Management of the infant with ambiguous external genitalia. The pediatric endocrinologist’s approach

      ea0011s78
    • Surgical management of ambiguous genitalia in the infant

      ea0011s79
    • Management of complex genital anomalies and the transition from childhood to adulthood: A patient’s perspective

      ea0011s80
  • Management of Graves' ophthalmopathy
  • • Prevention of thyroid eye disease

      ea0011s81
    • Medical treatment

      ea0011s82
    • Alternative immunomodulatory therapies for Graves’ ophthalmopathy

      ea0011s83
    • Ophthalmic management of thyroid eye disease

      ea0011s84
  • In vivo imaging of signalling
  • • OPT: a novel wholemount imaging technology for visualising gene & protein expression

      ea0011s85
    • A mouse reporting on estrogen receptor (ER) transcriptional activity to understand the complexities of female physiology in mammals

      ea0011s86
    • Micro PET-ing in mice

      ea0011s87
  • Contrasting practices in European endocrinology
  • • Diagnosis of hypercortisolism

      ea0011s88
    • Diagnosis of hypercortisolism

      ea0011s89
    • New endocrinology medicines: when are they good value?

      ea0011s90
    • Contrasting expenditure on expensive endocrine therapies – e.g. growth hormone

      ea0011s91
    • Contrasting practices in European endocrinology – radio-iodine therapy

      ea0011s92
    • Contrasting practices in European endocrinology. Radioiodine therapy. A Danish view

      ea0011s93
  • Research management workshop
  • • ea0011s94
    • ea0011s95
    • Funding for commercialisation of research after the biotech bubble

      ea0011s96
• Nurses Session
• • Metabolic syndrome
  • • Leptin expands function

      ea0011s97
    • Ghrelin update

      ea0011s98
    • Insulin resistance and type 2 diabetes – insights from the study of extreme human phenotypes

      ea0011s99
    • Metabolic syndrome

      ea0011s100
    • Nurse-led weight management: the Counterweight Programme

      ea0011s101
• Young Endocrinologists Session
• • Presenting your research – getting your work known
  • • Giving talks

      ea0011s102
    • Practical tips for a perfect poster

      ea0011s103
    • Papers for peer reviewed journals

      ea0011s104
    • PhD/MD Thesis: a recipe for success

      ea0011s105
    • Talking to a lay audience

      ea0011s106
• Oral Communications
• • Signal transduction OC1 Novartis Oncology Young Investigator Award
  • • Stress response after TIF-2 disruption: loss of grip on feedback control or adrenocortical impairment?

      ea0011oc1
    • Signalling and internalisation characteristics of corticotropin-releasing hormone (CRH) receptors

      ea0011oc2
    • Activation of cAMP (cAMP) binding protein (CREB) by gonadotrophin-releasing hormone (GnRH) requires calcium influx and PKC activity in gonadotroph cell lines

      ea0011oc3
    • The role of MRAP in the functional expression of the melanocortin 2 receptor

      ea0011oc4
    • The overexpression Pit-1 pathway, switch on by RET, get into apoptosis fate

      ea0011oc5
    • Activation of androgen membrane binding sites induce potent regression of prostate cancer cells in vitro and in vivo

      ea0011oc6
    • The effect of bone marrow stem cell (BMSC) differentiation on growth hormone receptor (GHR)-associated signalling pathways

      ea0011oc7
    • Role of the calcium-calmodulin dependent kinase II in oncogenic Ras-induced proliferation

      ea0011oc8
  • Steroids and reproductive endocrinology
  • • 11β-HSD1: anti-inflammatory mechanism in acute and chronic inflammation?

      ea0011oc9
    • Progesterone signaling in human myometrium is mediated through two novel membrane G protein coupled receptors

      ea0011oc10
    • The adrenal X-zone is involved in progesterone inactivation

      ea0011oc11
    • Expression profiling of genes in the testis of rhesus macaques during development and aging

      ea0011oc12
    • Anti-Müllerian hormone (AMH) production by granulosa cells from anovulatory PCO is 100 times higher than from normal ovaries, but is inhibited by metformin

      ea0011oc13
    • Endometrial intracrinology: Expression of 3β-hydroxysteroid dehydrogenase (3βHSD), and 17β-hydroxysteroid dehydrogenase type 5 (17βHSD-5)

      ea0011oc14
    • Role of the Hu proteins, HuR and HuD, and αCP1 in the regulation of androgen receptor expression and activity in prostate cancer cells

      ea0011oc15
    • 17β-estradiol regulates pituitary AnxA1 expression and externalization in vivo and in vitro

      ea0011oc16
  • Clinical endocrinology
  • • Copeptin, a precursor of vasopressin, in critically ill patients – an observational study

      ea0011oc17
    • Endoscope-assisted pituitary surgery for functioning and non-functioning pituitary adenomas. The experience of the first 80 patients in a single centre

      ea0011oc18
    • Disease remission in long term treated acromegalic patients after somatostatin analog withdrawal

      ea0011oc19
    • A European prospective real-life observational study of Quality of Life in patients with acromegaly

      ea0011oc20
    • Adjuvant radiation therapy of the tumor bed prevents local recurrences in adrenocortical carcinoma

      ea0011oc21
    • Detection of phaeochromocytoma: The emerging role of plasma metanephrines

      ea0011oc22
    • Improved Prognosis in Midgut Carcinoid patients by treating raised circulating Neurokinin A (NKA)

      ea0011oc23
    • Low testosterone and atherogenic lipid profile in aging men

      ea0011oc24
  • Diabetes and metabolism
  • • Cannabinoids increase AMP-activated protein kinase (AMPK) enzyme activity in the hypothalamus and heart via different signalling pathways – studies in CB1 knockout animals

      ea0011oc25
    • Neuropeptide S is a novel peptide which potently stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake

      ea0011oc26
    • A selective increase in adipose 11β-HSD1 expression in corticosterone-treated Pomc null mice is associated with development of metabolic syndrome

      ea0011oc27
    • 11β-Hydroxysteroid dehydrogenase type 1 oxo-reductase activity is increased in patients with alcoholic chronic liver disease: the key to the phenotype of the alcoholic pseudo-Cushing’s state?

      ea0011oc28
    • A choline deficient diet in mice prevents high fat diet induced insulin resistance in spite of more severe fatty liver disease

      ea0011oc29
    • The release of the adipocytokine visfatin is regulated by glucose and insulin

      ea0011oc30
    • Comparative analysis of the effects of dehydroepiandrosterone (DHEA) on white and brown pre-adipocyte proliferation/differentiation

      ea0011oc31
    • The in vitro effects of resistin on the innate immune signalling pathway in isolated human subcutaneous adipocytes.

      ea0011oc32
  • Neuroendocrinology and neoplasia
  • • Efect of overexpression of GH secretagogue receptor (GHSR) in the pituitary of transgenic mice

      ea0011oc33
    • Transgenic mice overexpressing Urocortin 3 show increased anxiety- and depressive-like behaviours but a hyporesponsive ACTH response to stress

      ea0011oc34
    • Immunocytochemical colocalisation of hormones in the human fetal pituitary

      ea0011oc35
    • Somatostatin analogues in the treatment of acromegaly: correlation between somatostatin receptor subtype expression levels and clinical response

      ea0011oc36
    • 90Y-DOTATATE in the treatment of neuroendocrine tumours

      ea0011oc37
    • Germline mutations in patients with apparently sporadic pheochromocytomas/paragangliomas

      ea0011oc38
    • 11 beta hydroxysteroid dehydrogense modulation of HPA function – importance of genetic background

      ea0011oc39
    • Expression of IGF-I & IGF-IR in tamoxifen sensitive and tamoxifen resistant breast cancer

      ea0011oc40
  • Endocrine genetics
  • • Mutations in Cullin 7, a cofactor for Ubiquitination, cause the 3M intra-uterine growth retardation syndrome

      ea0011oc41
    • Linkage of a fourth gene for familial glucocorticoid deficiency to chromosome 13q

      ea0011oc42
    • Mutation screening of SLC26A4 (PDS) gene in patients with Pendred syndrome and nonsyndromic enlarged vestibular aqueduct

      ea0011oc43
    • Functional impact of polymorphic variation in the gene encoding 11β-hydroxylase (CYP11B1): reduced adrenal 11-hydroxylase efficiency identifies a key intermediate phenotype in hypertension

      ea0011oc44
    • Genotype/phenotype correlation of PRKAR1A mutations in patients with Carney complex (CNC) and/or sporadic primary pigmented nodular adrenocortical disease (PPNAD) from the CNC network

      ea0011oc45
    • Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC-gene

      ea0011oc46
    • Frequent involvement of BMP15 gene variants in women with premature ovarian failure

      ea0011oc47
    • Progressive osseous heteroplasia: a phenotype associated with mutations of the GNAS1 gene

      ea0011oc48
  • Calcium and bone OC49 Novartis Oncology Young Investigator Award
  • • The A990G polymorphism of calcium sensing receptor gene (CASR) is associated with nephrolithiasis in patients with primary hyperparathyroidism (PHPT)

      ea0011oc49
    • Congenitally hypothyroid mice with (Pax8^−/−) or without (hyt/hyt) functional TSH receptors (TSHR) display equivalent skeletal phenotypes

      ea0011oc50
    • TSH receptor action in osteoblasts and osteoclasts in vitro

      ea0011oc51
    • In acromegaly bone mineral density depends on gonadal function

      ea0011oc52
    • Bone involvement in patients with adrenal incidentalomas: role of subclinical hypercortisolism

      ea0011oc53
    • Adult mice harbouring a dominant negative R384C mutation of TRalpha1 have a marked increase in trabecular bone and micro-mineralisation density

      ea0011oc54
    • Thyroid hormones stimulate osteoblast differentiation but inhibit mineralization of bone nodules in vitro

      ea0011oc55
    • The Scandinavian investigation of primary hyperparathyroidism (pHPT) – end of inclusion and preliminary results

      ea0011oc56
  • ThyroidOC57 British Thyroid Association Award
  • • Treatment of experimental hyperthyroid Graves’ disease with decoy TNF-family ligand receptors, suggests an essential role for BAFF in production of thyroid stimulating antibodies

      ea0011oc57
    • Interleukin 1: the optimal cytokine target in thyroid associated ophthalmopathy?

      ea0011oc58
    • Tri-iodothyronine improves haemodynamic performance and is associated with improved myocardial protection post on-pump coronary artery bypass grafting

      ea0011oc59
    • 4-methylbenzylidene-camphor (4MBC) causes pituitary effects comparable to hypothyroidism

      ea0011oc60
    • Phosphodiesterase-resistant PKA I agonists inhibit thyroid cancer cell growth

      ea0011oc61
    • The role of the thyroid hormone transporter monocarboxylate transporter 8 (MCT8) in fetal brain development

      ea0011oc62
    • Gender-specific differences in the expression of deiodinase I (Dio1) in mammals

      ea0011oc63
    • Thyroid hormone receptor TRβ1 mediates Akt activation by T3 in pancreatic β cells

      ea0011oc64
• Poster Presentations
• • Bone
  • • An audit of the role of Sestimibi imaging of the parathyroid glands in the management of parathyroid disease

      ea0011p1
    • Does adrenal function influence bone status in primary hyperparathyroidism? Preliminary results in a large series of patients at the time of the diagnosis

      ea0011p2
    • The effect of local radiotherapy on osteoprotegrin levels in patients with bone metastases

      ea0011p3
    • Clinical aspects of diabetic osteoarthropathy in type 1 and type 2 diabetes mellitus patients

      ea0011p4
    • Osteoporotic fractures in old subjects: role of functional and nutritional status and therapy effects during one year after fracture

      ea0011p5
    • Circulating osteoprotegerin and receptor activator of NF- κB ligand system in patients with beta-thalassemia major

      ea0011p6
    • The role of genetic individuality and phytoestrogens with minerals in prevention and treatment of Postmenopausal osteoporosis

      ea0011p7
    • Is there any combined influence of the N363S polymorphism in the glucocorticoid receptor gene and the BsmI polymorphism in the vitamin D receptor gene on the occurrence of glucocorticoid-induced osteoporosis in patients with bronchial asthma?

      ea0011p8
    • Bone mineral density in patients with type 1 diabetes

      ea0011p9
    • Thyroid hormone receptor alpha has a critical negative role in maintenance of the adult skeleton

      ea0011p10
    • PTH and phosphate circadian rhythms are altered in adult growth hormone deficient patients with low bone mineral density

      ea0011p11
    • Oral phosphate therapy used as an adjunct to growth hormone in adult growth hormone deficiency results in greater changes in bone mineral density compared with growth hormone replacement alone

      ea0011p12
    • Polymorphism in farnesil pirofosfato sintasi (FDPS) gene and relation with bone mineral density and response to aminobisfosfonate treatment

      ea0011p13
    • Do different generations of PTH assay induce different diagnosis in renal bone disease?

      ea0011p14
    • Management of primary hyperparathyroidism – are we following consensus guidelines?

      ea0011p15
    • Value of qualitative bone histology assessment in the evaluation of subjects with primary osteoporosis

      ea0011p16
    • Hearing impairment increases risk of bone fractures in women with Turner’s syndome

      ea0011p17
    • Evaluation of bone mineral density and markers of bone turnover in haemodialysis patients

      ea0011p18
    • The effect of ceramide on IGF-1 induced proliferation in growth plate chondrocytes

      ea0011p19
    • Treatment and follow up of primary hyperparathyroidism: 50 cases

      ea0011p20
    • Is there any relationship between the BsmI and FokI polymorphisms in the vitamin d receptor gene and bone mineral density in men?

      ea0011p21
    • Mutational Analysis of the PHEX gene in familial and sporadic cases of X-linked hypophosphatemia (XLH)

      ea0011p22
    • The reduction of bone mineral density in post-menopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH hormone secretion impairment

      ea0011p23
    • Effect of melatonin on gene expression and mineralization in mouse osteoblast culture

      ea0011p24
    • Effects of growth hormone administration on parathyroid hormone sensitivity and bone mineral metabolism in established osteoporosis

      ea0011p25
    • Is 1 g of calcium and 800 IU of Vitamin D sufficient to replenish Vitamin D stores in postmenopausal women with low bone density?

      ea0011p26
    • Synergistic induction of osteoblastic local glucocorticoid metabolism by inflammatory cytokines and glucocorticoids: a novel mechanism for glucocorticoid-induced bone disease

      ea0011p27
    • Evidence for high prevalence of hormonal irregularities in male osteoporosis

      ea0011p28
    • Evaluation of bone markers and structure in subclinical Cushing’s syndrome

      ea0011p29
    • Asymptomatic primary hyperparathyroidism: preliminary results of a prospetive randomized study on the effect of parathyroidectomy

      ea0011p30
    • Brown tumors in a patient with gluten enteropathy and masked primary (or tertiary) hyperparathyroidism

      ea0011p31
    • Baseline characteristics of postmenopausal Greek women with osteoporosis who had inadequate clinical response to antiresorptive medications.

      ea0011p32
    • Effect of grape procyanidins on TNF alpha mRNA expression and cell DNA damage in MC3T3-E1 osteoblast-like cells in vitro

      ea0011p33
    • The effects of Dexamethasone and Dehydroepiandrosterone (DHEA) on cytokines and receptor expression in a human osteoblastic cell line: potential steroid-sparing role for DHEA

      ea0011p34
    • Assessment of bone health and body composition in Glasgow school children

      ea0011p35
    • Assessment of bone mineral density (BMD) in patients with adrenal incidentaloma (ai): comparison between dual-energy x-ray absorptiometry (DEXA) and quantitative ultrasonometry (QUS)

      ea0011p36
    • A comparative study of neck ultrasonography, sestamibi scan and parathyroid surgery findings

      ea0011p37
    • Glucocorticoid metabolism in mouse osteoblasts: a model for the effects of local glucocorticoid generation on bone

      ea0011p38
    • Long-term growth hormone (GH) replacement in GH deficient adults – favourable effect on bone and body composition

      ea0011p39
    • Does parathyroidectomy reduce the risk of fractures and renal stones? Results of a systematic review and meta analysis

      ea0011p40
    • Brown tumors in hyperparathyroidism may be mistaken for primitive bone neoplasia: report of two cases

      ea0011p41
    • The effect of once-weekly Risedronate on biochemical markers of bone turnover after three month of treatment

      ea0011p42
    • Quantitative ultrasound at the hand phalanges in patients with acromegaly

      ea0011p43
    • Selenium supplementation restores the antioxidative capacity and prevents cell damage in mesenchymal stem cells in vitro

      ea0011p44
    • Expression of the membrane-associated hormone-sensitive protein UO-44 in hMSC-TERT immortalized mesenchymal stem cells

      ea0011p45
    • The effect of once-weekly Risedronate on biochemical markers of bone turnover after three month of treatment

      ea0011p46
  • Clinical case reports
  • • Forced conservative management of a patient with pituitary tumour apoplexy and reduced conscious level

      ea0011p47
    • An unusual presentation of ‘fits’

      ea0011p48
    • An unusual cause of confusion

      ea0011p49
    • Recurrent congenital neonatal hyperthyroidism in a mother with Graves’ disease (post radio-ablation) on thyroxine replacement

      ea0011p50
    • Isolated ACTH deficiency following long-term benzodiazepine treatment

      ea0011p51
    • Infertility and bilateral testicular masses due to 21-hydroxylase deficiency

      ea0011p52
    • Grave’s eye disease developing following radioiodine treatment for toxic nodular goitre

      ea0011p53
    • Recurrent hypoglycaemia: an unusual association of islet cell hyperplasia and coeliac disease

      ea0011p54
    • Screening of osteoporosis in a small Romanian town

      ea0011p55
    • Acute myocardial infarction and Graves’ thyrotoxicosis

      ea0011p56
    • Acromegaly, pregnancy and diabetes mellitus – a successful maternal and foetal outcome

      ea0011p57
    • Surgical management of metastatic phaeochromocytoma: review of 2 cases

      ea0011p58
    • The coincidence of mucoepidermoid and papillary thyroid carcinoma. A case report

      ea0011p59
    • DIre Straits - hypothalamic diabetes insipidus, acute myeloid leukaemia and high risk cytogenetics: 45,XX,t(3;3)(q21q26),-7

      ea0011p60
    • Metastatic insulinoma or not?

      ea0011p61
    • APECED (Autoimmune PolyEndocrinopathy-Candidiasis-Ectodermal Dystrophy) syndrome with atypical or incomplete presentation: report of 4 cases with AIRE mutations in heterozygosity

      ea0011p62
    • Relationship between age of onset, natural course and therapeutic approach in patients with acromegaly

      ea0011p63
    • Sweet’s syndrome and thyroid diseases: is there a link?

      ea0011p64
    • Bone marrow aplasia in a patient with panhypopituitarism responsive to sex hormone therapy. The importance of compliance with testoterone therapy

      ea0011p65
    • Multiple endocrine neoplasia type 1 (MEN1) in a patient with systemic mastocytosis

      ea0011p66
    • Brown tumour of the maxilla as the presenting feature of parathyroid carcinoma

      ea0011p67
    • Unexpected detection of thyroid cancer in a patient with presumed Graves’ thyrotoxicosis

      ea0011p68
    • Primary hyperparathyroidism (PHPT): Still a cause of hypertension resistant to therapy

      ea0011p69
    • Spontaneous pregnancy after trans-spenoidal surgery in a patient with pituitary hypophysitis – a case report

      ea0011p70
    • Adipsic diabetes insipidus following pituitary surgery for a macroprolactinoma

      ea0011p71
    • Regression of somatotropinoma in the course of treatment with octreotide in a female patient with acromegaly

      ea0011p72
    • Familial hyperparathyroidism with a mutation in the HRPT2 gene

      ea0011p73
    • Pendred’s syndrome with three mutations

      ea0011p74
    • About three cases of Riedel thyroiditis

      ea0011p75
    • Parathyroid carcinoma in a patient with chronic renal failure on long-term dialysis

      ea0011p76
    • Should prophylactic thyroidectomy be carried out in mucosal neuroma syndrome?

      ea0011p77
    • Synchronous malignant para-aortic phaeochromocytoma and vagal nerve paraganglioma in a patient with germline SDHB mutation

      ea0011p78
    • Ophthalmic presentations of Cushing’s syndrome

      ea0011p79
    • Long-term outcome of untreated Cushing’s syndrome due to pituitary microadenoma

      ea0011p80
    • Invasive prolactinoma with multiple recurrences: pituitary atypical adenoma or pituitary carcinoma? Report of a case

      ea0011p81
    • A case of primary pigmented micronodular hyperplasia as a cause of Cushing syndrome

      ea0011p82
    • Endocrine evaluation in a man with restrictive eating behaviour

      ea0011p83
    • Hypopituitarism in an adult thalassemic patient. Effects of different replacement therapies

      ea0011p84
    • Langerhans cell histiocytosis: management dilemma for the adult endocrinologist!

      ea0011p85
    • A case of bacterial endocarditis in a patient with acromegaly

      ea0011p86
    • Gitelman’s syndrome in pregnant, type 1 diabetic patient presented with foetal growth retardation, and bilateral hydronephrosis and hydroureter

      ea0011p87
    • The prolonged progressive course of acromegaly, complicated with diabetes mellitus, bilateral gonarthropathy, thyroid pathology and severe papillomatosis (clinical observation)

      ea0011p88
    • A case of adult GH deficit in a woman with Autoimmune Polyendocrine Syndrome type II

      ea0011p89
    • Spontaneous thrombosis of ophthalmic artery aneurysm causing isolated cortisol deficiency

      ea0011p90
    • Aortic involvement in Turner syndrome

      ea0011p91
    • Purely adrenaline-secreting phaeochromocytoma: a classical presentation of a rare entity

      ea0011p92
    • A scary awakening – acute paralysis in a young man

      ea0011p93
    • Systemic amyloidosis presenting with thyrotoxicosis: a case report

      ea0011p94
    • Unusual case of Pseudohypoparathyroidism type Ib

      ea0011p95
    • A case of Cushing’s syndrome and rapid course of illness

      ea0011p96
    • Primary adrenal insufficiency, gonadal failure and weak legs

      ea0011p97
    • Hypocalcemic cardiomyopathy in a patient with primary hypoparathyroidism and Fahr’s disease

      ea0011p98
    • An unusual case of panhypopituitarism associated with positive ANCA: atypical presentation of Wegener’s disease or lymphocytic hypophysitis?

      ea0011p99
    • Isolated secondary hypothyroidism in identical twins

      ea0011p100
    • Adrenal-insufficiency manifesting as hyperkalaemic paralysis

      ea0011p101
    • Hypercalcaemia and hypereosinophilic syndrome in a patient with cholangiocarcinoma

      ea0011p102
    • Di-George syndrome presenting with hypocalcaemia and personality disorder in adulthood – a case report

      ea0011p103
    • Phaeochromocytoma presenting as gestational diabetes

      ea0011p104
    • Conn’s syndrome associated with hyperprolactinaemia: two case reports. Hypertension was cured by surgery in both cases despite a 10 and 16 year history

      ea0011p105
    • Parathyroid carcinoma in multiple endocrine neoplasia (MEN) type 1: two case reports

      ea0011p106
    • Co-existing hypoparathyroidism and vitamin D deficiency causing life-threatening hypocalcaemia

      ea0011p107
    • A rare case of metastatic choroidal melanoma to the thyroid gland: the importance of cytology

      ea0011p108
    • A complex case of pregnancy and pegvisamont treated acromegaly

      ea0011p109
    • Post-partum thyroiditis (PPT): colour-doppler ultrasonography evaluation

      ea0011p110
    • Challenges of managing metabolic disturbances

      ea0011p111
    • Three generations of generalised resistance to thyroid hormone (GRTH)

      ea0011p112
    • Mineral-rich baths – an unusual source of exposure to excess iodine

      ea0011p113
    • Biochemical screening for ret negative medullary thyroid carcinoma (MTC): a case report highlighting difficulties in the interpretation of pentagastrin stimulated calcitonin testing

      ea0011p114
    • A long-standing lump in the neck proving troublesome for the surgeons

      ea0011p115
    • A case of isolated acth deficiency who developed autoimmune-mediated hypothyroidism and hepatitis

      ea0011p116
    • Cushing’s disease presenting as a Schizophreniform psychosis

      ea0011p117
    • Obesity, hypertension and elevated catecholamines

      ea0011p118
    • Cushing’s syndrome in an adolescent with MEN1: where is the lesion?

      ea0011p119
    • Glucagonoma: does the clinical expression depend on the presence of inherited disease?

      ea0011p120
    • A rare cause of gynaecomastia

      ea0011p121
    • Is the continuation of lithium treatment safe during peri-operative periods?

      ea0011p122
    • An unusual cause of jaundice

      ea0011p123
    • Severe thyrotoxicosis and pregnancy

      ea0011p124
    • Identification of two novel GALNT3 mutations in a patient with familial tumoral calcinosis (FTC)

      ea0011p125
    • Megadenoma

      ea0011p126
    • Autoimmune hypophysitis causing permanent diabetes insipidus – a case report

      ea0011p127
    • Time course of neuroendocrine dysfunction after aneurysmal subarachnoid hemorrhage – need for reassessment even years after the hemorrhage?

      ea0011p128
    • A case of late onset congenital adrenal hyperplasia in a female epileptic patient: implications for clinical practice

      ea0011p129
    • Adult-onset nesidioblastosis- a rare clinical case

      ea0011p130
    • Seeking an appropriate sex of rearing in 5 α-reductase deficiency

      ea0011p131
    • 49,XXXXY syndrome connected with hypothyroidism

      ea0011p132
    • Giant labia majora in familial partial lipodystrophy

      ea0011p133
    • Pituitary apoplexy and acromegaly: a case report

      ea0011p134
    • The effects of lanreotide administration vs unilateral adrenalectomy on disease activity in gip-dependent cushing’s syndrome

      ea0011p135
    • Epilepsy at presentation of macroprolactinoma

      ea0011p136
    • Difficulty to distinguish hyperandrogenia due to a tumoral formation or to polycystic ovary syndrome: a case report

      ea0011p137
    • Resolution of diagnostic uncertainties with DAX-1 gene mutation analysis

      ea0011p138
    • Multihormonal disorders in 17 year old girl with congenital hypoplastic anemia and secondary hemochromatosis

      ea0011p139
    • Carcinoid tumour: spontaneous regression following pregnancy

      ea0011p140
    • A rare cause of thyrotoxicosis and hypercalcemia

      ea0011p141
    • Maternal virilization and female fetal pseudohermaphroditism caused by exaggerating androgen secretion of pregnancy leutomas

      ea0011p142
    • Two unusual cases of extraadrenal phaeochromocytoma

      ea0011p143
    • Prolonged hungry bone syndrome in a patient with wolfram syndrome: a case report

      ea0011p144
    • Postmenopausal androgen excess: a clinical perspective

      ea0011p145
    • Using of pulse methylprednisolon therapy in Graves’ ophthalmopathy

      ea0011p146
    • Psycho-biological correlates of free-floating anxiety symptoms in male patients with sexual dysfunctions

      ea0011p147
    • Challenges in the management of an uncommon cause of diabetes insipidus

      ea0011p148
    • Psychiatric and movement disorders in primary hypoparathyroidism

      ea0011p149
    • A case report of malignant insulinoma

      ea0011p150
    • Malignant paraganglioma in young patient without symptoms – a case report

      ea0011p151
    • Secondary amenorrhoea induced by dihydrocodeine ingestion resolves following opiate withdrawal

      ea0011p152
    • Combined cortisol and aldosterone hypersecretion in two unusual cases of hypertension due to adrenocortical neoplasia

      ea0011p153
    • Endocrine disorders in a high secure hospital

      ea0011p154
    • Acromegaly with a double pituitary adenoma

      ea0011p155
    • 17beta-hydroxysteroid dehydrogenase deficiency caused by homozygous h271r mutation

      ea0011p156
    • Small intragenic somatic mutation associated with a germline mutation of HRPT2 gene in a patient with sporadic primary hyperparathyroidism

      ea0011p157
    • Plasma exchange for the prevention of severe thyrotoxic exacerbation following radioactive iodine therapy for Graves hyperthyroidism

      ea0011p158
    • Not-so-silent, silent corticotroph adenomas

      ea0011p159
    • Cushing’s syndrome presenting with palpitations

      ea0011p160
    • An unusual case of PTHrPoma with coexistent secondary hyperparathyroidism

      ea0011p161
    • False positive newborn screen for congenital hypothyroidism due to a TSH-IgG (macro-TSH) complex

      ea0011p162
    • Familial Hypocalciuric Hypercalcemia (FHH) caused by P748L mutation in the calcium sensing receptor (CaSR) gene

      ea0011p163
    • Importance of complex evaluation of the changes in ST-segment in ECG: case report of the patient with Addison disease and Brugada syndrome

      ea0011p164
    • Metformin-associated lactic acidosis in a caucasian woman precipitated by acute renal failure treated with bicarbonate haemodialysis

      ea0011p165
    • Dysgerminoma and gonadoblastoma in children with complete androgen insensibility

      ea0011p166
    • Chronic autoimmune thyroid disease in children and adolescents in Lower Silesia in the years 1999–2004

      ea0011p167
    • Three extreme cases of electrolyte imbalance-induced seizures

      ea0011p168
    • Two cases of idiopathic primary hypoparathyroidism

      ea0011p169
    • Cushing’s syndrome due to medullary thyroid carcinoma – a case report

      ea0011p170
    • Polymyalgia rheumatica and Hashimoto thyroiditis

      ea0011p171
    • Addison’s disease: Soy Sauce – a lifesaving concoction

      ea0011p172
    • Pretibial Myxoedema: Is this a marker for occult thyroid ophthalmopathy?

      ea0011p173
    • An unusual carcinoid tumor in a case of Cushing syndrome

      ea0011p174
  • Clinical practise and governance
  • • Audit on management of chronic adrenal insufficiency

      ea0011p175
    • Salivary cortisol daycurve and Quality of Life assessment in optimizing glucocorticoid replacement therapy in patients with Addison’s disease

      ea0011p176
    • Symptom-specific thresholds for testosterone deficiency modulate complaints and metabolic risk in 434 aging male patients

      ea0011p177
    • Longterm experience of more than 8 years with a novel formulation of testosterone undecanoate (Nebido) in substitution therapy of hypogonadal men

      ea0011p178
    • Improvements for patients and nurses using 2.5 ml prefilled syringes as the vehicle solution for suspension of Sandostatin LAR^® microspheres

      ea0011p179
    • Impaired thirst and AVP release due to a reset osmostat in a patient with partial cranial diabetes insipidus (CDI) and subtle pituitary disease

      ea0011p180
    • Reactive hypoglycaemia – can measuring insulin concentrations help understand the pathophysiology and support diagnosis?

      ea0011p181
    • Impaired quality of life in patients with adrenal insufficiency – evidence that improved glucocorticoid replacement strategies are needed

      ea0011p182
    • Long-acting, intramuscular TestosteronE undecanoatE (TU, Nebido^®) in the treatment of female-to-male transgender individuals

      ea0011p183
    • Long-acting intramuscular testosterone undecanoate (TU, Nebido^®) in treatment of hypogonadal aging males

      ea0011p184
    • Screening in primary care using fasting glucose uncovers significant hypoglycaemia including an asymptomatic insulinoma

      ea0011p185
    • Comparison of the effect of sibutramine monotherapy with sibutramine-metformin combination therapy in nondiabetic obese women

      ea0011p186
    • Torbay adrenal and pituitary project

      ea0011p187
    • Autoimmune hypoadrenalism: the profile of related conditions

      ea0011p188
    • Recombinant hGH therapy in males with organic GHD: should we trust in total testosterone levels for diagnosis of central hypogonadism?

      ea0011p189
    • Survey of steroid replacement therapy

      ea0011p190
    • Concordance between GH determination and IGF-I in acromegaly using two IGF-I methods

      ea0011p191
    • Adult turner syndrome clinic: what are the patients’ perceptions of this specialist service?

      ea0011p192
    • Adequacy of post-glucose gh nadir <1 μg/l to define biochemical and neuroradiological remission of acromegaly

      ea0011p193
    • Patients with serum prolactin >20,000 mU/l – review of presentation, management and outcome

      ea0011p194
    • Long-term outcome in men with microprolactinoma

      ea0011p195
    • Ophthalmic findings in turner syndrome

      ea0011p196
    • Early detection of diabetic autonomic neuropathy with a new device

      ea0011p197
    • Adult growth hormone replacement therapy after the institution of NICE guidelines

      ea0011p198
    • Clinical evaluation of sheehan syndrome

      ea0011p199
    • Is a repeat or resting prolactin necessary in the investigation of hyperprolactinaemia?

      ea0011p200
    • Knowledge of testosterone replacement therapy is significantly correlated with patient satisfaction suggesting greater need for education

      ea0011p201
    • Cushing’s disease – an audit of outcomes following pituitary surgery from a single centre

      ea0011p202
    • Clinical characterization of patients with hyperprolactinaemia due to macroprolactin

      ea0011p203
    • Total cortisol and calculated free cortisol during the 250 μg ACTH test

      ea0011p204
    • Comparison of the effects of transdermal and oral oestrogen treatments on serum and salivary cortisol concentrations

      ea0011p205
    • A survey of gender dysphoria (transsexual) patients attending an endocrine clinic

      ea0011p206
    • Osteoporosis, osteopaenia and osteoarthritis in autoimmune hypoadrenalism

      ea0011p207
    • Autoimmune hypoadrenalism: symptoms at diagnosis

      ea0011p208
    • Does HT still have a place? The impact on menopausal-related symptoms

      ea0011p209
    • High mortality rate in hospital inpatients with hyponatraemia

      ea0011p210
  • Comparative endocrinology
  • • The patients with HIV lipodystrophy syndrome have lower total fat mass but similar free fat mass

      ea0011p211
    • Dynamic macroprolactin and adjusted prolactin responses in hyperprolactinaemic patients

      ea0011p212
    • Retrospective study of usefulness of Sestamibi scan in primary hyperparathyroidism

      ea0011p213
    • Assessment of oxidative stress in patients with polycystic ovarian syndrome treated with either Orlistat or Metformin

      ea0011p214
    • Prognostication in canine parvoviral diarrhoea using basal serum cortisol concentrations

      ea0011p215
    • Short-term effects of propionate on the leptin system and on G protein-coupled receptor GPR41 mRNA levels in adipose tissue of goats

      ea0011p216
    • Ontogeny of galanin and vasotocin immunoreactivity in the supraoptic nucleus (SON) and the bed nucleus of the stria terminalis (BSTM) in chickens

      ea0011p217
  • Cytokines and growth factors
  • • The role of IL-4 and IFN-gamma as prognostic factors of major adverse cardiac events in patients with ST-elevation myocardial infarction assigned primary percutaneous coronary intervention

      ea0011p218
    • Adiponectin and resistin concentrations during oral glucose tolerance test (OGTT) in insulin-resistant subjects

      ea0011p219
    • Effects of IGF-2 on glucose metabolism

      ea0011p220
    • Interleukin 6 and transforming growth factor beta1 concentration in serum in patients with coronary vessels restenosis

      ea0011p221
    • Immunosuppressive effect of recombinant human erythropoietin

      ea0011p222
    • Low dose dexamethasone does not alter serum adiponectin or resistin concentrations

      ea0011p223
    • Interleukin-6 and TNF-alpha in hemodilaysis patients: association with obesity and metabolic syndrome

      ea0011p224
    • Vegf and sVCAM in patients with adrenal gland tumors

      ea0011p225
    • Prolactin deficiency is independently associated with reduced IGF-I status in severely GHD adults

      ea0011p226
    • GH/IGF-I axis and haematological alterations in anorexia nervosa

      ea0011p227
    • Selected hormones serum levels in dependence on BMI and sex

      ea0011p228
    • Abnormalities of humoral immunity with reduced immunogenicity to pneumococcal vaccine in panhypopituitarism

      ea0011p229
    • Lack of influence of an IGF-I gene polymorphism on circulating IGF-I levels in severely GHD adults

      ea0011p230
    • Serum TGF-β-1 levels in non-alcoholic steatohepatitis

      ea0011p231
    • Subclinical hypothyroidism could be regarded as benign condition in oxidative stress but not in atherosclerosis

      ea0011p232
    • Low TGF beta-1 serum levels in idiopathic male osteoporosis

      ea0011p233
    • Possible predictive value of IGF-II mRNA expression in breast cancer (BC)

      ea0011p234
    • IGF II protein expression in breast cancer. Relationship with the most important predictive parameters in breast malignancy

      ea0011p235
    • The effect of growth hormone replacement on the diurnal and ultradian dynamics of ghrelin and leptin in adult growth hormone deficiency

      ea0011p236
    • Growth hormone receptor extracellular domain linked to glycophosphatidyl inositol (GHR-GPI); a potential growth hormone receptor antagonist

      ea0011p237
    • The depot specific expression of NPY in human adipose tissue and its upregulation under hyperinsulinaemic conditions in isolated human adipocytes

      ea0011p238
    • The role of BMPs in the establishment of zona glomerulosa in the adrenal gland

      ea0011p239
    • Anosmin-1: a novel cofactor for fibroblast growth factor receptor 1

      ea0011p240
    • Effect of growth hormone deficiency in adults on insulin action and gene expression of selected adipokines in subcutaneous adipose tissue

      ea0011p241
    • Soluble interleukin 2 receptor is elevated in sera of women with Graves’ disease and has relation to serum free thyroxin and thyroid volume

      ea0011p242
    • Molecular mechanisms of idiopathic muscle hypertrophy in humans

      ea0011p243
    • CD4 T-cell count improves during sustained IGF-I response following low dose growth hormone therapy in HIV-infected patients on stable antiretroviral regimens. A pilot study

      ea0011p244
    • The differential influence of specific plant lectins on insulin and IGFs binding to solubilised placental membrane IGF and insulin receptors

      ea0011p245
    • GH and GH antagonist B2036 effect on the immune system

      ea0011p246
    • IGF-I modulates HIF-1α and HIF-2 α in Kaposi Sarcoma

      ea0011p247
    • Proinflammatory cytokine gene expression shows intrinsic circadian oscillation in peripheral cells

      ea0011p248
    • Plasma interleukin 18 in patients with polycystic ovary syndrome – relation to insulin resistance

      ea0011p249
    • Expression of functional toll-like receptors in adipocytes

      ea0011p250
  • Diabetes, metabolism and cardiovascular
  • • The involvement of GH-IGF-I axis in a mouse model of type II diabetic nephropathy

      ea0011p251
    • Sodium bicarbonate reacts with polysaccharides starch to enhance exercise

      ea0011p252
    • New function for the enzyme amylase discovered: amylase works as a catalyst/hydrolyzing agent to break down, disaccharides (sucrose, lactose, maltose… etc) and polysaccharides (starch)

      ea0011p253
    • Liver GH receptor signaling in type I diabetic mice

      ea0011p254
    • The effects of changes in insulin sensitivity on androgen supply values in diabetic men at different age

      ea0011p255
    • The effect, in clinical practice, of long-acting fluvastatin (LAF) on low density lipoprotein-cholesterol (LDL-Ch) in patients with type 2 diabetes mellitus (T2DM) in which other statins have failed to achieve the goals

      ea0011p256
    • Nutritional outcome in end-stage renal disease diabetic patients: short term follow-up of patients initiating/escaping dialysis

      ea0011p257
    • Improvement of nutritional status in non-dialysed uremic diabetic patients

      ea0011p258
    • Subthalamic nucleus stimulation in parkinsonian patients does not increase serum ghrelin levels

      ea0011p259
    • Hyperandrogenism as a risk factor of coronary artery disease in young women

      ea0011p260
    • Comparison of urinary N-Acytyl β-D glucoseaminidase activity in diabetic patients and controls

      ea0011p261
    • Association of hypogonadism and type 2 diabetes in men attending an outpatient erectile dysfunction clinic

      ea0011p262
    • Estimation of the lipid metabolism in women with gestational diabetes mellitus (part 2). Differences resulting from the method of treatment

      ea0011p263
    • Estimation of some parameters of lipid metabolism in pregnant women with gestational diabetes mellitus

      ea0011p264
    • The role of a lifestyle modification in preventing type II diabetes mellitus in subjects with high-risk factors

      ea0011p265
    • The effect of Greek mediterranean diet on trace elements and blood coagulation factors in type 2 diabetic patients

      ea0011p266
    • 12 month audit of insulin glargine use in the diabetic clinic

      ea0011p267
    • Increased expression of the adipokines resistin and fiaf in hypoxic/ischemic mouse brain

      ea0011p268
    • Prevalence of chronic cardiovascular complications in newly diagnosed type 2 diabetic patients

      ea0011p269
    • Hormonal profile associated with the insulin sensitive obese subjects

      ea0011p270
    • AT₁ receptor activation mediated oxidative stress and uncoupling protein-2 driven beta-cell dysfunction in obesity-induced Type 2 diabetes mellitus

      ea0011p271
    • Effects of hyperglycemia on the AT₁ receptor expression and secretory function in an INS-1E beta-cell line

      ea0011p272
    • Evaluation of Garlic extract effect on serum angiotensin converting enzyme (ACE) level in streptozotocin-diabetic rats

      ea0011p273
    • Determinants of metabolic syndrome and insulin resistance in hemodialysis patients

      ea0011p274
    • Hyperlactatidemia caused by acute myocardial infarction in patients with type 2 diabetes mellitus

      ea0011p275
    • The safety and efficacy of chinese herbal medicine PHS-e2 (Glucoherb) in streptozotocin – induced diabetic wistar rats

      ea0011p276
    • Education for diabetic patients for fasting of Ramadan: a questionnaire study

      ea0011p277
    • Alcohol intake deteriorates insulin receptors and adipokines expression in rat adipose tissue

      ea0011p278
    • Des-acyl ghrelin regulates glucose and lipid metabolism in HL-1 cardiomyocytes

      ea0011p279
    • Regulation of brain-derived resistin and FIAF in a novel hypothalamic neuronal cell line

      ea0011p280
    • Myocardial ischemia in type 1 diabetic patients – re-examination after four years

      ea0011p281
    • The metabolic syndroma presence in peripheral arterial occlusive disease of diabetic patients

      ea0011p282
    • A TCF1 mutation may cause transient congenital hyperinsulinism followed by MODY3

      ea0011p283
    • Waist circumference cut-offs for categorisation among Tunisian adult population

      ea0011p284
    • Associations between bmi and smoking with reference to other life style factors, the 4th and the 5th Tromsø studies

      ea0011p285
    • Gene variants at calpain-5 locus are associated with obesity and other features of metabolic syndrome

      ea0011p286
    • Plasma concentrations of asymmetric dimethyl arginine and total homocysteine in siblings of type 2 diabetes mellitus

      ea0011p287
    • Mortality risks of diabetic patients who reach end stage renal disease (ESRD) in the united states: age and gender differences

      ea0011p288
    • Hormonal profile in men suffering from coronary artery disease and metabolic syndrome

      ea0011p289
    • The impact of vitamins and/or minerals supplementation on blood pressure in type 2 diabetes

      ea0011p290
    • Pro12Ala PPAR gamma2 gene polymorphism in PCOS women - the role of the satiety and insulin activity regulating compounds

      ea0011p291
    • Glucose metabolism, insulin secretion and insulin sensitivity in juvenile hemochromatosis

      ea0011p292
    • Glucocorticoids are metabolised within perivascular adipose: the link between metabolic diseases and their vascular consequences?

      ea0011p293
    • Absence of sexual dimorphism in the symptomatic responses to hypoglycaemia in adults with and without type 1 diabetes

      ea0011p294
    • Metabolic syndrome and insulin sensitivity in early glycoregulation disorders

      ea0011p295
    • Biochemical predictors of the cardiovascular complications in patients with obesity and type 2 diabetes

      ea0011p296
    • Decreased cardiac and arterial noradrenaline and dopamine concentrations occur concomitantly with the development of type II diabetes in rats treated neonatally with monosodium glutamate (MSG): a possible basis for autonomic neuropathy?

      ea0011p297
    • Gender distribution in Ukrainian adult insulin-treated diabetics depending of age at diagnosis

      ea0011p298
    • Effects of arm exercise on metabolic parameters in type 2 diabetic patients

      ea0011p299
    • The ethanolic extract of Combretum decandrum Roxb. improved glucose tolerance and increased glucose uptake of hyperinsulinemic rats

      ea0011p300
    • In-patients food intake and reasons of non-consumption

      ea0011p301
    • Renal expression of alpha-ENaC is increased in testosterone treated rats

      ea0011p302
    • Insulin resistance syndrome (IRS) and non-alcoholic fatty liver disease (NAFLD) in obese children: influence of ethnic background, sex, age and family history of type 2 diabetes (T2DM)

      ea0011p303
    • Serum ghrelin levels during oral glucose challenge – new insights from gastrectomized patients

      ea0011p304
    • A gene gene interaction of single nucleotide polymorphisms within two oxidative stress genes affects arterial compliance in patients with coronary artery disease

      ea0011p305
    • The variable number of tandem repeat polymorphism in the NOS3 gene is associated with arterial compliance and insulin resistance in coronary artery disease

      ea0011p306
    • Altered cholesterol and bile acid homeostasis in the hexose-6-phosphate dehydrogenase (H6PDH) knockout mouse

      ea0011p307
    • Insulin secretion in HBV and HCV infected patients with type 2 diabetes mellitus

      ea0011p308
    • The pancreatic beta-cells autoantibodies in HBV and HCV infested patients with type 2 diabetes mellitus

      ea0011p309
    • Adrenomedullin increases the expression of CLR and RAMP2 in microvascular endothelial cells

      ea0011p310
    • Sympathetic function in carriers of MC4R mutations

      ea0011p311
    • A case of myocardial infarction induced by factitious hypoglycaemia in type 2 diabetes patient

      ea0011p312
    • Orlistat improves postprandial triglyceride metabolism in obese patients with or without diabetes

      ea0011p313
    • Challenge in Achieving Target Hba1c in a relatively rare Diabetes complication

      ea0011p314
    • Depot specific activation of inflammatory signalling molecules JNK and NFκB in human abdominal subcutaneous and omental adipose tissue

      ea0011p315
    • Endothelial, inflammatory and endocrine markers in women with PCOS before and after metformin treatment

      ea0011p316
    • Expression and regulation of adiponectin receptors (AdR-1 and AdR-2) in pancreatic beta-cells

      ea0011p317
    • Cardiovascular risk factors and macrovascular complications in type 2 diabetes

      ea0011p318
    • Effects of Ezetimibe on serum lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL cholesterol apheresis and high dose atorvastatin therapy

      ea0011p319
    • Effect of micronised fenofibrate on plasma levels of c-reactive protein in combined hyperlipidemia

      ea0011p320
    • Long term safety of Atorvastatin and Fenofibrate therapy in patients with combined hyperlipidemia

      ea0011p321
    • Use of insulin glargine during pregnancy in women with type 1 diabetes mellitus

      ea0011p322
    • Serum ferritin levels and obesity

      ea0011p323
    • Utility of continuous glucose monitoring (CGMS) to explore glycemic patterns in patients with diabetes mellitus in the UAE

      ea0011p324
    • Dyslipidemia in premenopausal and postmenopausal obese women

      ea0011p325
    • The effect of moxonodine on endothelial dysfunction in metabolic syndrome

      ea0011p326
    • The BsmI and FokI polymorphisms in the vitamin D receptor gene in relation to anthropometric and biochemical parameters describing metabolic syndrome

      ea0011p327
    • Comparison between NPH insulin and insulin glargine in intensive insulin therapy in type 1 diabetes mellitus

      ea0011p328
    • Association of c-reactive protein with insulin resistance in first degree relatives of diabetic patients

      ea0011p329
    • How does glucose insulin potassium improve haemodynamic performance? Evidence for beta-adrenoreceptor and sarcoplasmic reticulum calcium ATPase up-regulation

      ea0011p330
    • Effects of weight loss on the coronary risk profile in obese patients two years after bariatric surgery

      ea0011p331
    • The severity of cardiovascular disease in women is modified by estrogen receptor alpha polymorphic variants

      ea0011p332
    • Adult pancreatic islet progenitor cells exhibit plasticity in vitro

      ea0011p333
    • Regulation of hexose-6-phosphate dehydrogenase (H6PDH) in human fetal liver WRL-68 cells

      ea0011p334
    • Relationships between plasma adiponectin and testosterone concentrations in middle-aged men and women

      ea0011p335
    • Relationship between testosterone and in vivo expression of adipoR1 in skeletal muscle in middle aged Caucasian men

      ea0011p336
    • Testosterone secretion and melatonin rhythm in men with the metabolic syndrome

      ea0011p337
    • Mortality and morbidity are objective epidemiological indices that reflect state of diabetic aid in region

      ea0011p338
    • Prevalence of diabetic foot syndrome among diabetes patients

      ea0011p339
    • Decreased cutaneous vasomotor responses in patients with insulin resistance

      ea0011p340
    • Lipid profile in normal weight and obese women with polycystic ovary syndrome

      ea0011p341
    • Is ghrelin a potential signal of decreased fat-free mass in elderly subjects?

      ea0011p342
    • Obesity and expression of serotonin transporter (SERT) in human platelets

      ea0011p343
    • Acute and chronic effect of teriparatide on glucose metabolism in women with established osteoporosis

      ea0011p344
    • Adipose glucocorticoid synthesis: transcription of the 11β-hydroxylase gene in omental but not subcutaneous adipose tissue

      ea0011p345
    • Metabolic syndrome among patients with primary aldosteronism: a common feature?

      ea0011p346
    • Metabolic parameters in patients with primary aldosteronism: relation to snps of the adiponectin gene

      ea0011p347
    • Coronary artery disease and heart failure in diabetic patients in the north of portugal

      ea0011p348
    • Physiological concentrations of testosterone inhibit extracellular calcium entry via voltage-gated calcium channels in the A7r5 vascular smooth muscle cell line - a non-genomic effect

      ea0011p349
    • Comparison between premixed insulin aspart 30 vs premixed human insulin 30/70 in combination with metformin in obese type 2 diabetic patients

      ea0011p350
    • Effect of repaglinide vs glimepirid on glycaemic control in overweight and obese patients with type 2 diabetes mellitus uncontrolled by metformin

      ea0011p351
    • Association of an insertion/deletion polymorphism in the alpha 2B adrenergic receptor with essential hypertension in diabetic patients

      ea0011p352
    • The metabolic syndrome and insulin resistance in polycystic ovary syndrome – study over 40 patients

      ea0011p353
    • Prevalence of registered diabetic nephropathy and its terminal stages

      ea0011p354
    • Noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS) caused by an activating glucokinase mutation

      ea0011p356
    • Relationship between plasma visfatin levels and the metabolic variables in metabolic syndrome

      ea0011p357
    • The vasodilatory action of oestrogen in isolated human pulmonary arteries

      ea0011p358
    • The effect of fluvastatin on adiponectin and insulin sensitivity

      ea0011p359
    • Leptin as a regulator of serum acylated ghrelin in normal-weight and obese premenopausal women

      ea0011p360
    • Insulin receptoropathies are distinguished from other syndromes of severe insulin resistance by elevated plasma adiponectin levels

      ea0011p361
    • Impaired endothelial function in young non-obese women with polycystic ovary syndrome: Normalization with Ethinyl Estradiol-Cyproterone Acetate treatment

      ea0011p362
    • Carbohydrate metabolism in children with Down syndrome

      ea0011p363
    • Anti-oxidative effect of 17beta-estradiol in human endothelial cells: the role of Bcl-2

      ea0011p364
    • Emergence of new addictions following gastric reduction surgery for morbid obesity

      ea0011p365
    • Is there male androgenetic alopecia the sign of male equivalent of polycystic ovary syndrome or metabolic syndrome?

      ea0011p366
    • Increased prevalence of the metabolic syndrome by NCEP, WHO and IDF criteria in women with PCOS

      ea0011p367
    • Estrogen receptor alpha (ER ‘alpha’) gene polymorphisms and first-ever primary intracerebral hemorrhage (PICH)

      ea0011p368
    • The metabolic control levels of 548 diabetic outpatients compared with the current guidelines of Polish Diabetes Association (PDA)

      ea0011p369
    • Increased sub-clinical inflammation and markers of vascular injury in obese children

      ea0011p370
    • Clinical, functional and polysomnographics parameters in severely obese patients

      ea0011p371
    • The role of tumour necrosis factor-alpha in insulin-stimulated endothelial nitric oxide production

      ea0011p372
    • Correlation of WBC and PLT count with parameters of type 2 diabetes mellitus

      ea0011p373
    • Field evaluation of a multi-sensor armband in Greek women

      ea0011p374
    • The acute stimulation of nitric oxide synthesis by rosiglitazone in human aortic endothelial cells is independent of the PPAR gamma receptor but is dependant on the fuel sensing enzyme AMPK

      ea0011p375
    • Dehydroepiandrosterone in relation to obesity, insulin resistance and lipid spectra in Czech non-diabetic population

      ea0011p376
    • Frequency of dyslipidemiαs in children – results of lifestyle intervention

      ea0011p377
    • SiRNA-mediated depletion of synaptotagmin-11 abrogates insulin-stimulated glucose uptake in 3T3-L1 adipocytes

      ea0011p378
    • Chromosome 1p shows significant linkage to steroid metabolism in hypertension in the British Genetics of Hypertension Study

      ea0011p379
    • Impaired glucose metabolism in patients with Cushing’s Syndrome

      ea0011p380
    • Effects of bariatric surgery on preclinical myocardial alterations in severe obesity and the related role of insulin resistance

      ea0011p381
    • The effect of an 18 week group exercise education program on weight, physical activity, cardiovascular fitness, quality of life and attitudes to exercise in obese irish female adults

      ea0011p382
    • Direct effect of cannabinoids and ghrelin on liver and adipose cell metabolism via the AMP-activated protein kinase (AMPK) enzyme

      ea0011p383
    • Expression and Localisation of human tissue kallikrein in transfected human embryonic kidney cells (HEK-293). Development of a novel panel of monoclonal antibodies (mAbs) against human tissue kallikrein

      ea0011p384
    • Dietary regulation of peripheral glucocorticoid action: comparison of saturated and unsaturated fats

      ea0011p385
    • The KCNJ11 E23K and UCP2 G-866A SNPs in relation to DM2 in Czech population

      ea0011p386
    • Androgen regulation of hepatic glucocorticoid metabolism in obese Zucker rats

      ea0011p387
    • Plasma N-terminal pro-brain natriuretic peptide and adiponectin levels increases during weight loss

      ea0011p388
    • Multiple signalling pathways are involved in the phosphorylation of ERK1/2 upon activation of human OX1R and OX2R: Evidence for differential modulation by orexin-A and orexin-B

      ea0011p389
    • Association among individual deprivation using the EPICES score and anthropometric factors linked to abdominal and metabolic markers

      ea0011p390
    • Mapping of adiponectin and adiponectin receptors in the human adult and fetal heart

      ea0011p391
    • Testosterone replacement therapy reduces insulin resistance, and improves glycaemic control in hypogonadal men with Type 2 diabetes

      ea0011p392
    • Functional analysis of cardiac orexin receptors: preferential activation by OR-B

      ea0011p393
    • Orexin receptor expression in human adipose tissue: differential effects of orexins

      ea0011p394
    • Insulin sensitivity and lipid profile in obese and normal weight hypertensive subjects

      ea0011p395
    • Human adipocytes attenuate cardiomyocyte contraction. A direct link between heart failure and obesity

      ea0011p396
    • Dietary potassium driven responses in the renal WNK kinase pathway in vivo

      ea0011p397
    • The in vitro and in vivo role of diabetic status and insulin sensitisers on the novel adipocytokine, visfatin

      ea0011p398
    • Adrenocortical function in obese Zucker rats

      ea0011p399
    • Recurrence rate of atrial fibrillation in amiodarone-induced hyperthyroidism

      ea0011p400
    • The effect of hyperthyroidia on glycemic control in patients with diabetes mellitus

      ea0011p401
    • Flow mediated dilatation and svcam concentration as the markers of endothelial dysfunction in patients with acromegaly

      ea0011p402
    • Low endogenous testosterone induces fatty streak formation following cholesterol feeding in the testosterone deficient testicular feminised mouse and castrated male

      ea0011p403
    • Testosterone replacement reduces aortic fatty streak formation in testosterone deficient Tfm mice following feeding on a cholesterol-enriched diet

      ea0011p404
    • Growth hormone and IGFBP-3 but not IGF-1 are independent predictors for insulin sensitivity in healthy subjects: on the role of hGH in the metabolic syndrome

      ea0011p405
    • Dehydroepiandrosterone inhibits differentiation, proliferation and 11β-hydroxysteroid dehydrogenase type 1 activity in human preadipocytes

      ea0011p406
    • Urocortin 2 mediates glucose utilization and insulin sensitivity in skeletal muscle

      ea0011p407
    • Elevated serum hs-CRP in the obese – still much to be explained

      ea0011p408
    • Lipoprotein Lp(a) in patients with systemic lupus erythematosus

      ea0011p409
    • Effects of alcoholic extract of walnut (Juglans regia L.) septum on serum lipids and Activities of serum aminotransaminase enzymes in streptozocin-induced diabetic rats

      ea0011p410
    • The ways in which zinc enters beta cells in the pancreas and the influence of zinc blockers on the development of type 1 diabetes

      ea0011p411
    • Lipoprotein Lp(a) in patients with rheumatoid arthritis

      ea0011p412
    • Polymorphisms in insulin-like growth factor binding protein-1 (IGFBP-1) are associated with altered circulating IGF-I and lower body mass index in type-2 diabetes mellitus

      ea0011p413
    • Polymorphisms in insulin-like growth factor binding protein-1 (IGFBP-1) are associated with increased type-2 diabetes mellitus prevalence

      ea0011p414
    • Cardiac autonomic neuropathy in relation to some components of metabolic syndrome in newly diagnosed type 2 diabetic patients

      ea0011p415
    • Severity of depression in patients with type 1 and type 2 diabetes and its relation to the level of glycemia control and anti-depressive therapy

      ea0011p416
    • Cardiac autonomic and peripheral neuropathy in newly diagnosed type 2 diabetic patients

      ea0011p417
    • Rapid effect of repaglinide in combination with metformin in poorly controlled obese patients with type 2 diabetes mellitus

      ea0011p418
    • Impact of migration on circulating adipocytokines in an Asian Indian population

      ea0011p419
    • Migration to the UK results in significantly lower testosterone levels in South Asian men

      ea0011p420
    • Prevalence of skin manifestations in diabetics

      ea0011p421
    • Correlations between leptin, insulin resistance and lipid profile in postmenopausal women

      ea0011p422
    • Correlation between glycemia levels and mortality rate in patients with type 2 diabetes and prior myocardial infarction

      ea0011p423
    • Left ventricular geometry and contractile ability in type 2 diabetes and non-diabetic patients with mild hypertension

      ea0011p424
    • Effect of lacidipine on left ventricular mass and blood pressure circadian rhythm in hypertensive diabetic patients

      ea0011p425
  • Endocrine disruptors
  • • Prevalence of the phyto-oestrogen urinary metabolites enterodiol and enterolactone in patients under endocrine investigation

      ea0011p426
    • Comparative review of primary and secondary empty sella syndrome

      ea0011p427
    • Adult’s primary empty sella

      ea0011p428
    • The UV filter benzophenone 2 inactivates human recombinant thyroperoxidase in vitro and disturbs thyroid hormone homeostasis in rats

      ea0011p429
    • Endocrine disorders in thallasaemia – local experience in an inner city hospital in Birmingham, England

      ea0011p430
    • Extracts of black cohosh (Actaea racemosa) inhibit growth of MCF-7 and MDA-MB-231 breast cancer cells and dose-dependently inhibit oestrone sulphatase activity

      ea0011p431
    • Androgen-dependent Sertoli cell proliferation as a target for endocrine disruptors relevant to human male reproductive health

      ea0011p432
    • A randomized, open-label, multicenter study to evaluate octreotide LAR with surgical therapy as primary therapy patients with acromegaly

      ea0011p433
    • Origin of dysgenetic areas in testes of rats exposed to Di n-butyl phthalate (DBP) during fetal life: A model of human testicular dysgenesis syndrome

      ea0011p434
    • Endocrine disruptors and idiopathic gynecomastia with aromatase gene polymorphism

      ea0011p435
    • Loss and resumtion of ovarian function after mitotane administration

      ea0011p436
  • Endocrine tumours and neoplasia
  • • Estrogen receptor alpha and beta (ERα and -β) gene and protein expression in breast cancer cell lines: verification by RT-PCR and Western blotting

      ea0011p437
    • Challenges associated with the diagnosis, differential diagnosis and treatment of 4 cases of ACTH-dependent Cushing’s syndrome due to intermittent hypercortisolism

      ea0011p438
    • Hyperprolactinaemia in a series of adults with craniopharyngiomas and Rathke’s cleft cysts: what are the upper limits?

      ea0011p439
    • Parathyroid scinigraphy for hyperparathyroidism, an assessment of performance

      ea0011p440
    • Insulinomas – an experience from a tertiary care institution in South India

      ea0011p441
    • Biological diagnosis of 63 pheochromocytomas and/or paragangliomas

      ea0011p442
    • Dedifferentiated papillary thyroid cancer. Use of array CGH in searching for prognostic markers

      ea0011p443
    • Stereotactic conformal radiotherapy in pituitary adenomas – outcome in 36 consecutive patients during years 1996–2004

      ea0011p444
    • Intra-ovarian adrenocortical carcinoma

      ea0011p445
    • Comparative efficacy of therapy with sandostatin and parlodel in patients with acromegalia

      ea0011p446
    • Pituitary tumors in republic of Croatia

      ea0011p447
    • Histological peculiarities of pituitary adenomas

      ea0011p448
    • Surgical treatment in acromegaly: predictors of outcome

      ea0011p449
    • Pituitary mass and hypothyroidism. A case report

      ea0011p450
    • Incidence rate of thyroid cancer in Olsztyn region in the years 1993–2004

      ea0011p451
    • A typical clinical picture of four insulinoma cases

      ea0011p452
    • What is the best glycaemic index for the diagnostic of insulinoma?

      ea0011p453
    • Sustained correction of hypercortisolism with a low dose mitotane regimen in a young woman with PPNAD and Carney Complex

      ea0011p454
    • Hypocorticism after radiosurgery (protonotherapy) in patients with normal MRI and in patients with confirmed tumor for Cushing’s disease

      ea0011p455
    • Prognostic value of KI-67 expression in the cytologic identification of pancreatic endocrine tumors: preliminary data

      ea0011p456
    • Difficulties in diagnosing persistent acromegaly using current consensus criteria for cure after transsphenoidal surgery

      ea0011p457
    • Carbohydrate metabolism in patients with hypercorticism

      ea0011p458
    • Role of family history for diabetes mellitus in determining insulin resistance in acromegalic patients

      ea0011p459
    • Familial acromegaly

      ea0011p460
    • Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro

      ea0011p461
    • Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH₂

      ea0011p462
    • An intrasellar germinoma with normal cerebrospinal fluid β-HCG concentration misdiagnosed as hypophysitis

      ea0011p463
    • Response to medical treatment in male macroprolactinomas

      ea0011p464
    • Non functioning pituitary tumors

      ea0011p465
    • Diabetic retinopathy in acromegaly

      ea0011p466
    • Malignant catecholamine-secreting paragangliomas of retrocardial localization

      ea0011p467
    • Short-term evaluation of quality of life in acromegalic patients

      ea0011p468
    • Octreotide as alternative to surgically adrenalectomy

      ea0011p469
    • Inhibition of IGF-II signal transduction improves chemosensitivity in human adrenocortical cancer cells

      ea0011p470
    • The new TNM classification is inferior to the Lee classification in predicting outcome in patients with adrenocortical carcinoma

      ea0011p471
    • Stimulated and spontaneous growth hormone release in irradiated acromegalic patients

      ea0011p472
    • WNT4 expression in normal human adrenals and adrenocortical tumours

      ea0011p473
    • The clinical particularities, medical possibility of prolactonomas in men

      ea0011p474
    • Management of thyroid cancer in children

      ea0011p475
    • Diagnosis difficulties in insulinomas

      ea0011p476
    • Insulin-like growth factor-i signalling in tamoxifen sensitive and tamoxifen resistant breast cancer cells

      ea0011p477
    • Functioning adrenocortical carcinoma and the clinical endocrinologist: toxic treatments and poor prognosis

      ea0011p478
    • Post-operative serum cortisol for prediction of long-term remission from Cushing’s syndrome

      ea0011p479
    • An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinoma

      ea0011p480
    • Macroprolactinoma: 5 cases

      ea0011p481
    • 48 h appears as sufficient duration of fasting in the diagnosis of insulinoma – a single centre experience with 23 cases

      ea0011p482
    • A case of a patient with differentiated thyroid carcinoma and metastases to the kidneys

      ea0011p483
    • Development of a non-isotopic immunoassay for the measurement of aldosterone in saliva

      ea0011p484
    • Thyroid autoimmunity disorders and breast cancer (BC): absence of morphological autoimmune changes in breast malignant tissue

      ea0011p485
    • Pituicytoma – a case report

      ea0011p486
    • PTTG promotes a novel VEGF-KDR-ID3 autocrine mitogenic pathway in thyroid cancer

      ea0011p487
    • Multiple Endocrine Neoplasia Type 1 (MEN 1) is associated with insulin resistance and an increased prevalence of diabetes and impaired fasting glucose

      ea0011p488
    • Evaluation of a standardized protocol for the collection and storage of adrenal tumor samples – preparation for an European adrenal tumor bank (ENS@T)

      ea0011p489
    • Value of overnight dexamethasone suppression test (1 mg-dst) in subclinical Cushing’s syndrome

      ea0011p490
    • Effect of catecholamine uptake inhibition on catecholamine content in human adrenal chromaffin cells and pheochromocytes

      ea0011p491
    • PTTG binding factor (PBF) can transform cells independently of interaction with PTTG

      ea0011p492
    • Carney’s complex with acromegaly as the leading clinical condition

      ea0011p493
    • Daily profiles of aldosterone secretion in primary aldosteronism

      ea0011p494
    • Analysis of succynyl dehydrogenase (SDH) subunits gene mutations in patients with paragangliomas

      ea0011p495
    • Neuropeptide Y-Y1 receptors mediate the effects of neuropeptide Y on prostate cancer cell growth

      ea0011p496
    • Differential expression of neurogenins by human pituitary adenomas

      ea0011p497
    • Evidence for an attenuated 11 β-hydroxysteroid dehydrogenase type-1 (11βHSD1) response to an inflammatory stimulus in primary cultures of epithelial ovarian cancer

      ea0011p498
    • Long-term somatostatin analog octreotide treatment in insulinoma patients

      ea0011p499
    • Development of dopamine agonist resistance and progression from microadenoma to macroadenoma in two women with hyperprolactinaemia

      ea0011p500
    • The rare RET mutation (insTTCTdelG) at codon 666 is associated with a low penetrance of medullary thyroid carcinoma and pheochromocytoma

      ea0011p501
    • Use of TRH in addition to CRH stimulation during bilateral inferior petrosal sinus sampling in Cushing’s syndrome – long term experience

      ea0011p502
    • Glucagonoma syndrome – treatment with intensive insulin and high dose vitamin B

      ea0011p503
    • Headaches cured by surgery

      ea0011p504
    • Chromogranin-A in adrenal incidentalomas – marker for tumour secretion

      ea0011p505
    • A novel germ-line mutation gly321arg in the exon 5 of the ret proto-oncogene detected in a family with familial medullary thyroid carcinoma

      ea0011p506
    • Contemporary management of macroprolactinomas

      ea0011p507
    • Cushing’s paraneoplastic syndrome secondary to recurrent ovarian carcinoma

      ea0011p508
    • Moleculargenetic and clinical characterisation of neurofibromatosis type 1 – associated pheochromocytoma

      ea0011p509
    • AcroBel: a registry and survey on acromegaly in Belgium

      ea0011p510
    • The latest safety and efficacy data of patients treated with Pegvisomant

      ea0011p511
    • Mutation at codon 804 detected in a Greek kindred by screening of the RET gene in patients with medullary thyroid carcinoma

      ea0011p512
    • A rare RET gene mutation is found in two apparently unrelated Greek kindreds with familial medullary thyroid carcinoma

      ea0011p513
    • Surgical cure with preserved pituitary function is rare in acromegalic patients. Results from the Preoperative Octreotide Treatment of Acromegaly (POTA) study

      ea0011p514
    • Different scintigraphic patterns between sympathetic and parasympathetic paragangliomas

      ea0011p515
    • mRNA expression of somatostatin receptor subtypes in pheochromocytomas/paragangliomas

      ea0011p516
    • A retrospective review of the effect of pituitary radiotherapy after transsphenoidal surgery for non-functioning pituitary adenomas

      ea0011p517
    • Biochemical characteristics of ‘silent’ ACTH-secreting pituitary adenomas: Preoperative serum and urine hormone studies

      ea0011p518
    • Radiotherapy and o,p’-DDD induce an inhibition of growth and interfere in the cell cycle in H295-R adrenocortical cell line

      ea0011p519
    • Role of PKA regulatory subunit 2B protein on cortisol-secreting adrenocortical cells proliferation

      ea0011p520
    • Outcome of management of craniopharyngiomas – a contemporary series

      ea0011p521
    • Anatomo-clinical features in multihormonal prolactinomas

      ea0011p522
    • Glucocorticoid receptor gene N363S variant in patients with clinically inapparent adrenal adenomas

      ea0011p523
    • Characteristics and follow up of thyroid cancer in patients with hyperthyroidism

      ea0011p524
    • Investigation and surgical management of pancreatic neuroendocrine tumours

      ea0011p525
    • Estrone and cortisol co-secreting adrenocortical carcinoma in a man presenting with hypogonadotrophic hypogonadism and painful gynaecomastia

      ea0011p526
    • Origin and spread of the SDHD p.Y114C mutation causing head and neck paraganglioma in Trentino, Italy

      ea0011p527
    • Characterization of familial non-syndromic pheochromocytoma

      ea0011p528
    • Endostatin and VEGF levels in serum of patients with pituitary tumors

      ea0011p529
    • 18F-deoxy-D-glucose positron emission tomography (FDG_PET) increases the detection rate of recurrent or residual medullary thyroid cancer

      ea0011p530
    • Papillary thyroid microcarcinoma: a low risk neoplasia?

      ea0011p531
    • The value of fluorine-18 fluorodeoxyglucose PET during follow-up of patients with medullary thyroid carcinoma

      ea0011p532
    • N363S and BclI variants in the glucocorticoid receptor gene and their associations in Cushing’s syndrome and Addison’s disease

      ea0011p533
    • Novel inactivating mutations in four Italian cases of familial hypocalciuric hypercalcemia

      ea0011p534
    • Genetic analyses of familial isolated primary hyperparathyroidism: implications for clinical assessment and surgical management

      ea0011p535
    • Non-pancreatic carcinoid tumours - prognostic value of proliferative index (Ki67%)

      ea0011p536
    • Somatostatin receptor subtypes 1–5 in pituitary tumors of various etiologies: investigation by immunohistochemistry

      ea0011p537
    • High performance liquid chromatography (HPLC) in the follow-up of mitotane therapy in a patient with adrenal carcinoma

      ea0011p538
    • Multiple endocrine neoplasia type 1 and angiomyxoma

      ea0011p539
    • Novel L30LR heterozygous mutation of the menin gene in a Hungarian MEN 1 family

      ea0011p540
    • Differences in the presenting biochemical and imaging data in patients with acromegaly caused by pure GH adenomas, adenomas with GH and PRL cell differentiation and plurihormonal adenomas

      ea0011p541
    • Management of thyrotrophin-secreting adenoma with octreotide therapy

      ea0011p542
    • Tumor size and gonadotrophin immunoreactivity of pituitary adenomas

      ea0011p543
    • Carotid arterial intima-media thickness (IMT), a marker of atherosclerosis, does not differ in patients with acromegaly compared to healthy controls

      ea0011p544
    • Acute biliary tract problems are common on discontinuation of somatostatin analogue (SA) therapy

      ea0011p545
    • Cell proliferation and outcome of GH-secreting pituitary adenomas

      ea0011p546
    • Efficacy and safety of high doses of long-acting somatostatin analogues for treatment of well differentiated functioning neuroendocrine tumors

      ea0011p547
    • Surgical debulking of GH secreting adenomas improves control of acromegaly by lanreotide – a prospective study

      ea0011p548
    • Diagnostic utility of dexamethazone suppression tests in the work-up of Cushing’s disease

      ea0011p549
    • Descriptive epidemiology of thyroid cancer occurring in the population living in the Rhône Alpes region: 1998–2004

      ea0011p550
    • In vitro effects of som230 on primary cultured pheochromocytoma cells

      ea0011p551
    • Fourier transform infrared spectroscopy (FTIR) of parathyroid pathology

      ea0011p552
  • Growth and development
  • • Prevalence of the main GH receptor polymorphisms in GH deficient children and in the general population

      ea0011p553
    • Developmental control of tissue deiodinases by cortisol in fetal sheep during late gestation

      ea0011p554
    • Significance of neonatal steroid imprinting and of peripubertal growth hormone excess for the development of prostatic hyperplasia in the rat

      ea0011p555
    • Adrenal (interrenal) development in the zebrafish

      ea0011p556
    • Comparison of dietary pattern and food habits in urban and rural adolescent girls in Gilan/IRAN

      ea0011p557
    • Effective factors on status of nutritional education in primary school children, Tehran, Iran: A Focus Group Discussion (FGD)

      ea0011p558
    • Morphological changes of pituitary region in primary GH deficiency

      ea0011p559
    • Growth without growth hormone: normal final height of four patients with multiple pituitary hormone deficiency

      ea0011p560
    • RAD21-dependent effects of securin/PTTG and separase on fetal neuronal NT2 cells

      ea0011p561
    • Leukemia inhibitory factor promotes the chemomigration of immature GNRH neurons

      ea0011p562
    • The study of nutrition with different salt concentrations in prenatal period on BP, tissue changes NA and aldosterone level in next generation

      ea0011p563
    • Sodium, Birth weight, adult weight and Bp in adulthood

      ea0011p564
    • Embryonic gene expression affected by different sodium concentrations

      ea0011p565
    • Sodium changes autonomic nervous response

      ea0011p566
    • Lipid peroxidation, activity of caspase 3 and apoptosis activation in low birth weight children

      ea0011p567
    • Growth hormone induced improvement in quality of life does not correlate with reduction in vascular risk in adult hypopituitary patients

      ea0011p568
    • The response of infant’s adrenal gland and salt appetite, aldosterone and Na serum level to mother’s salt consumption

      ea0011p569
    • Maternal testosterone levels during pregnancy are associated with offspring size at birth

      ea0011p570
    • Mortality in growth hormone deficiency

      ea0011p571
    • The cardiovascular risk profile and carotid IMT of adults with partial GH deficiency

      ea0011p572
    • Double blind placebo controlled study on the impact of RGH replacement on quality of life in patients with severe growth hormone deficiency

      ea0011p573
    • Prolonged expression of the ACTH receptor, MC2-R, during 3T3-L1 adipocyte differentiation is dependent upon switching promoter usage to an adipocyte-specific, C/EBP-driven, downstream promoter

      ea0011p574
  • Neuroendocrinology and behaviour
  • • Association between the LRP5 gene and serum post-menopausal follicle stimulating hormone levels

      ea0011p575
    • Structural analysis of somatotrophs and lactotrophs in annexin 1 null mice

      ea0011p576
    • Dietary supplements for stress and obesity co-morbidities reduction

      ea0011p577
    • The impact of hypothalamic-pituitary (h-p) irradiation on the TSH Bio/Immuno (B/I) ratio in the fed and fasting states

      ea0011p578
    • Comparison of the catecholaminergic response to 2 different stressors in healthy men

      ea0011p579
    • Effect of gastric bypass and gastric banding on neurotensin levels in morbidly obese patients

      ea0011p580
    • Mental and neuropsychological disorders of children with congenital hypothyroidism

      ea0011p581
    • Hypopituitary patients have a high occurrence of metabolic syndrome markers and an increased prevalence of cardiovascular risk factors

      ea0011p582
    • Spontaneous GH secretion in the fed and fasting states in cranially irradiated adult cancer survivors with normal peak GH responses to two provocative tests: does GH neurosecretory dysfunction exist?

      ea0011p583
    • The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis

      ea0011p584
    • GH secretion in amyotrophic lateral sclerosis

      ea0011p585
    • Clinical significance of macroprolactin

      ea0011p586
    • ADH and thirst function in defence with hypernatremia formation

      ea0011p587
    • The effect of garlic odor on appetite center

      ea0011p588
    • Taste protective mechanism in relation with salt

      ea0011p589
    • The effect of salt on night sleep

      ea0011p590
    • Evaluation of cognitive functions by using p300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and gh excess

      ea0011p591
    • Appetite regulating hormones in constitutionally lean and anorexia nervosa subjects

      ea0011p592
    • Differentiation of TSH-oma from thyroid hormone resistance syndrome using thyroid color Doppler sonography

      ea0011p593
    • Maternal consumption of a high-meat, low carbohydrate diet in late pregnancy and stress responsiveness in the offspring

      ea0011p594
    • Patients with pituitary disease who have had radiotherapy have reduced cerebral vasomotor reactivity

      ea0011p595
    • An open label, controlled study to assess the ability of patients with acromegaly, or their partners, to administer Somatuline Autogel^®

      ea0011p596
    • The effect of dopamine on neuroendocrine disorders in women with PCOS under chronic stress conditions

      ea0011p597
    • Measurement of basal cortisol in serum and saliva for the diagnosis of secondary adrenal insufficiency

      ea0011p598
    • Sensitivity and specificity of different provocative tests for the diagnosis of secondary hypoadrenalism in patients with hypothalamo-pituitary disorders

      ea0011p599
    • Pulmonary function in Cushing’s disease

      ea0011p600
    • Adenosine stimulates connexin 43 expression and increases intercellular communication in the folliculostellate cells of the anterior pituitary gland

      ea0011p601
    • Complement C5a inhibits the secretion of macrophage migration inhibitory factor (MIF) in anterior pituitary cell lines

      ea0011p602
    • Unrecognized chronic hypopituitarism in patients who survived hemorrhagic fever with renal syndrome

      ea0011p603
    • Ghrelin test for the assessment of growth hormone (GH) status in successfully treated patients with acromegaly

      ea0011p604
    • The thickening of the pituitary stem In connection with 06 cases

      ea0011p605
    • Effectiveness of the association of Bromocriptine and Cabergoline in the treatment of 05 invasif and giants prolactin macroadenoma

      ea0011p606
    • Hypothalamic-pituitary dysfunction following irradiation of non-pituitary brain tumours in adults

      ea0011p607
    • Bone mass and metabolism in active acromegaly – no impact of gonadal status. a study of 73 patients

      ea0011p608
    • Effect of pegvisomant on glucose metabolism

      ea0011p609
    • Psychological and gastrointestinal problems in anorexia nervosa patients

      ea0011p610
    • Octreotide shrinks the cellular rather than the vascular compartment in acromegalic tumours in vivo

      ea0011p611
    • Positive correlation between AcroQol and SF-36 and negative with BDI in sample of 60 acromegalics

      ea0011p612
    • Quality of life (QoL) and psychiatric sequelae following aneurysmal subarachnoid hemorrhage (SAH): Does neuroendocrine dysfunction play a role?

      ea0011p613
    • Pituitary function in patients with detectable serum pituitary autoantibodies

      ea0011p614
    • Prevalence of pituitary autoantibodies in thyroid disorders

      ea0011p615
    • Rate of change in size of macroprolactinomas with dopamine agonist therapy – is there any relationship to fall in prolactin concentrations?

      ea0011p616
    • The levels of ghrelin and leptin and body fat mass in patients treated for thyroid dysfunction

      ea0011p617
    • Night sleep affected by salt

      ea0011p618
    • ADH and Thirst Function in Defence with Hypernatremia Formation

      ea0011p619
    • Taste protective mechanism in relation with salt

      ea0011p620
    • Cushing’s syndrome as a model to investigate the effects on cognition of high circulating levels of glucocorticoid

      ea0011p621
    • The influence of growth hormone replacement (GHR) in adults with GH deficiency (GHD) on body composition, basal metabolic rate, physical activity and ingestive behaviour

      ea0011p622
    • Influence of affective changes on cortisol response to ACTH

      ea0011p623
    • Interest of a single treatment by somatostatin analogues in a macroadenoma secreting TSH and GH

      ea0011p624
    • Dehydroepiandrosterone (DHEA) improves psychological well-being in male and female hypopituitary patients in addition to growth hormone replacement (GHR)

      ea0011p625
    • The influence of a GH receptor antagonist (GHRA) on the relationship between GH and IGF-I in adults with severe growth hormone deficiency (AGHD)

      ea0011p626
    • Can adults with severe growth hormone deficiency (AsGHD) and a low IGF-I be distinguished from those with a normal IGF-I?

      ea0011p627
    • Sleep disorders in acromegaly: preliminary data demonstrating a high prevalence of restless leg syndrome (RLS)

      ea0011p628
    • Risk factors for the development of atherosclerosis in patients with acromegaly

      ea0011p629
    • Microalbuminuria as well as insulin sensitivity are improved under octreotide-lar treatment in acromegalic patients

      ea0011p630
    • Pro-opiomelanocortin and ACTH, precursors of alphaMSH, are secreted from human melanocytes and keratinocytes and can stimulate melanogenesis

      ea0011p631
    • Processing and sorting of pro-opiomelanocortin is an important checkpoint in regulating release of ACTH from secretory vesicles in pituitary cells

      ea0011p632
    • Hormone therapy effects on sleep and dreams in menopausal women

      ea0011p633
    • Glucose-suppressed GH levels compared with IGF-I levels in patients with acromegaly

      ea0011p634
    • Loss of rise in awakening cortisol response in prepubertal survivors of leukaemia post bone marrow transplantation and chemotherapy treatment

      ea0011p635
    • The incidence of spontaneous cerebro-spinal fluid rhinorrhea in a large series of patients with macroprolactinoma

      ea0011p636
    • Gonadotropin levels in the cerebrospinal fluid (CSF) as a marker of the gonadotropin secretion from non-functioning pituitary adenomas

      ea0011p637
    • Prolonged post-operative follow-up is necessary for unirradiated non-functioning pituitary adenomata

      ea0011p638
    • Anterior pituitary hormone dysfunction after traumatic brain injury: less common than previously thought?

      ea0011p639
    • Effects of long-term GH treatment in Prader-Willi adults

      ea0011p640
    • Endocrine abnormalities are common in transsexual individuals

      ea0011p641
    • Glucagon-induced suppression of ghrelin secretion is exerted at hypothalamus-pituitary level and is not mediated by an increase in catecholamine secretion

      ea0011p642
    • Complications of hormonal therapy in male to female transsexuals is uncommon

      ea0011p643
    • Effects of targeted ablation of GHRH neurons in mice on anterior pituitary somatotrophs and lactotrophs

      ea0011p644
  • Reproduction
  • • Spermatogenesis in autologous testicular transplants in the non-human primate Callithrix jacchus

      ea0011p645
    • Hormonal status of women with benign endometrial hyperplastic lesions

      ea0011p646
    • Dependence of semen characteristics on abstinence time, testicular volume and hormones

      ea0011p647
    • Plasma endothelin-1 levels in patients with male hypogonadism

      ea0011p648
    • Outcome of 59 pregnancies in 43 acromegalic women

      ea0011p649
    • Difficulties in achieving versus maintaining erection: organic, psychogenic and relational determinants

      ea0011p650
    • Psycho-biological correlates of smoking in patients with erectile dysfunction

      ea0011p651
    • Psycho-biological correlates of delayed ejaculation in male patients with sexual dysfunctions

      ea0011p652
    • Psycho-biological correlates of free-floating anxiety symptoms in male patients with sexual dysfunctions

      ea0011p653
    • Histone deacetylase inhibitors exert estradiol-induced proliferation and hyperplasia formation in the mouse uterus

      ea0011p654
    • Aetiologies of galactorrheas

      ea0011p655
    • Standardisation and validation of a sensitive enzymeimmunoassay procedure to estimate 13,14-dihydro-15-keto-PGF_2α (PGFM) in mithun (Bos frontalis) plasma

      ea0011p656
    • “Siofor” efficacy in treatment of obesity and reproductive disorders

      ea0011p657
    • Endothelin-1 levels in men of reproductive age with idiopathic hypogonadism after treatment with tamoxifen or raloxifene

      ea0011p658
    • Clinical, hormonal, neuroradiological characteristics and response to treatment in 29 macroprolactinomas

      ea0011p659
    • Prevalence of macroprolactinemia during pregnancy of women with prolactin-producing pituitary microadenomas

      ea0011p660
    • Hormone replacement therapy in postmenopausis fails to normalize gonadotropins – does it matter?

      ea0011p661
    • All that is hypogonadal in haemochromatosis is not due to iron deposition

      ea0011p662
    • Nitric-oxide-cGMP and ATP-cAMP pathways in pregnant women with gestational diabetes mellitus

      ea0011p663
    • The influence of estradiol on erythrocyte antioxidative enzyme system activity in pre- and postmenopausal women

      ea0011p666
    • The influence of the Cimicifuga Racemosa on the vegetovascular and psychoemotional disorders in women with climacteric syndrome

      ea0011p667
    • Gonadal dysfunction in hypercortisolic men

      ea0011p668
    • Role of estrogen receptor α- or β-isoforms in sex-specific brain organization

      ea0011p669
    • An immortalised cell line (SK11) derived from immature mouse testes express functionally active androgen and oestrogen receptors

      ea0011p670
    • Clinical and laboratory relationships in women with hirsutism as a primary symptom

      ea0011p671
    • Bone mass density in 180 women with premature ovarian failure

      ea0011p672
    • Oxidized low-density lipoprotein autoantibodies in patients with polycystic ovary syndrome

      ea0011p673
    • Transforming growth factor beta 1 and decidualisation of the human endometrium

      ea0011p674
    • Evidence for synergy of SHBG and androgen receptor genes in PCOS phenotype

      ea0011p675
    • Factor analysis identifies three independent factors within PCOS

      ea0011p676
    • Impaired vascular function in hypogonadal males is unaltered during monthly treatment cycle with intramuscular testosterone esters

      ea0011p677
    • Changes in GnRH gene expression in the medial basal hypothalamus of rhesus macaques across the menstrual cycle

      ea0011p678
    • Mechanisms of Wolffian duct differentiation; development of a model for studying androgen-driven stromal-epithelial interactions

      ea0011p679
    • Neonatal, but not maternal, plasma lipid profiles are altered in pregnancy in women with polycystic ovarian syndrome (PCOS), compared with weight matched controls

      ea0011p680
    • Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males

      ea0011p681
    • Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat

      ea0011p682
    • Neuromedin U (NMU) and Neuromedin S (NMS) function as putative rregulators of the gonadotropic axis in the rat

      ea0011p683
    • Circadian changes in melatonin secretion and its relationship to gonadotropins in premenopausal women

      ea0011p684
    • Serum levels of PSA do not change in healthy pre-menopausal and in menopausal women, but are increased in subjects with polycystic ovary syndrome (PCOS)

      ea0011p685
    • Expressions of KISS1 and GPR54 are differentially regulated by estradiol and GnRH in adult female rat pituitary

      ea0011p686
    • Anti-Mullerian hormone (AMH) production by and amh type-II receptor (AMHRII) in normal human ovaries

      ea0011p687
    • Identification and functional study of a new FSH receptor gene mutation in women affected by polycystic ovary syndrome (PCOS)

      ea0011p688
    • Plasma kisspeptin is a novel tumour marker in patients with gestational trophoblastic neoplasia

      ea0011p689
    • Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats

      ea0011p690
    • Oxidative stress, endothelial function, and arterial stiffness in young patients with polycystic ovary syndrome

      ea0011p691
    • Aldosterone and renin plasma levels in young patients with polycystic ovary syndrome

      ea0011p692
    • Association between polymorphisms within the SUR1/Kir6.2 gene region and polycystic ovary syndrome: a case-control study

      ea0011p693
    • Effect of family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome

      ea0011p694
    • A review of cimetidine (tagamet) effects as a reoproductive toxicant in male rats prostate and seminal vesicle

      ea0011p695
    • A review of male rat genital system morphology followed cimetidine injection

      ea0011p696
    • A review of cimetidine (tagamet) effects as a reoproductive toxicant in male rats leydig cells

      ea0011p697
    • Functional restoration of intact rabbit ovary after cryopreservation and transplantation

      ea0011p698
    • Effects of metformin therapy in lean subjects with pcos on insulin resistance indices

      ea0011p699
    • Comparison of various insulin sensivity indices in idiopathic hirsutism

      ea0011p700
    • Metformin therapy decreases hyperandrogenism and hyperinsulinaemia in women with polycystic ovary syndrome

      ea0011p701
    • A unique subgroup of patients with polycystic ovary syndrome identified by clinical and biochemical features

      ea0011p702
    • Obstetric hazards of maternal obesity

      ea0011p703
    • Cardiopulmonary impairment in young women with polycystic ovary syndrome

      ea0011p704
    • Metformin decreases CRP level and cardiovascular risk in PCOS women

      ea0011p705
    • Functional characterization of the follicle-stimulating hormone receptor core promoter: applying a comparative approach among primates

      ea0011p706
    • Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes

      ea0011p707
    • Androgenic status is influenced by AR polymorphism (CAG repeats number)

      ea0011p708
    • Role of D327N sex-hormone binding globulin gene polymorphism in the pathogenesis of polycystic ovary syndrome

      ea0011p709
    • Endocrine evaluation of a large cohort of male cancer survivors compared with healthy controls

      ea0011p710
    • The use of prolonged human chorionic gonadotrophin stimulation testing in the evaluation of undescended testes

      ea0011p711
    • Stage-specific mRNA expression of androgen receptor correlated with FSH receptor in individual pre-antral follicles isolated from human ovary

      ea0011p712
    • Hyperprolactinaemia due to big prolactin

      ea0011p713
    • Efficacy of Testogel in the treatment of hypogonadism in routine clinical practice

      ea0011p714
    • Which clinical features of polycystic ovary syndrome are improved with metformin therapy? A retrospective study

      ea0011p715
    • Comparison of Insulin Resistance levels in pre and post-menopausal women, women with polycystic ovarian syndrome and postmenopausal women with Type 2 Diabetes

      ea0011p716
    • 11β-hydroxysteroid dehydrogenase (11βHSD) activities in porcine granulosa cells from ovarian follicles and cysts

      ea0011p717
    • Secretion of adiponectin by human placenta: differential modulation by cytokines

      ea0011p718
    • Functionality of largest follicles is affected in gonadotrophin-stimulated cycles

      ea0011p719
    • Screening for gene SRY by FISH in patients with Turner Syndrome

      ea0011p720
    • Serum Anti-Mullerian hormone (AMH) concentrations in infants and children

      ea0011p721
    • Prenatal diagnosis of P450 oxidoreductase deficiency

      ea0011p722
    • Isolated progesterone secretion by an ovarian Leydig cell tumour: I, hormonal and immunohistochemical characterization II, effects on the gonadotrope axis

      ea0011p723
    • Serum inhibin levels in patients with polycystic ovary syndrome

      ea0011p724
    • Outcomes of pregnancy and glycaemic control in patients with type 1 diabetes

      ea0011p725
    • Characteristic changes of skin and it’s accessories in relation to diabetic peripheral neuropathy in patients with type 2 diabetes mellitus

      ea0011p726
  • Steroids
  • • High risk of adrenal insufficiency after single intra- or peri-articular steroid administration in young healthy sportsmen

      ea0011p727
    • Capillary blood, an alternative to saliva for the diagnosis of Cushing’s syndrome?

      ea0011p728
    • Gonadal dysfunction in male hypercortisolic subjects

      ea0011p729
    • A ras recruitment screen for glucocorticoid receptor-interacting proteins using the entire receptor as bait

      ea0011p730
    • Hormones of cortex of adrenal glands in patients after cardiac arrest in early postresuscitation period

      ea0011p731
    • Clinical presentation of a patient with novel mutation in CYP17 gene

      ea0011p732
    • Hypothalamic-pituitary-adrenal axis in diabetes: role of autonomic unbalance

      ea0011p733
    • Establishing circadian rhythm profiles for salivary testosterone in women: evidence of decline during ageing

      ea0011p734
    • Prevalence of classical forms of 21-hydroxylase deficiency in Western Siberia according to the results of neonatal screening of congenital adrenal hyperplasia

      ea0011p735
    • The New Zealand White Albino Rabbit is a suitable model for the evaluation of 11β-hydroxysteroid dehydrogenase type 1 activity in ocular tissues

      ea0011p736
    • Androgen status in women with hypogonadotropic hypogonadism

      ea0011p737
    • Long-term glucocorticoid repression of pro-opiomelanocortin (POMC) expression

      ea0011p738
    • A novel CYP11B2 gene mutation in an Asian family with aldosterone synthase deficiency

      ea0011p739
    • Long-term effect of flutamide, metformin and their combination in dieting obese women with polycystic ovary syndrome

      ea0011p740
    • Can the 250mcg synacthen test be used to screen for primary hyperaldosteronism?

      ea0011p741
    • The functional consequences of local glucocorticoid metabolism in synovial fibroblasts

      ea0011p742
    • Challenges in paediatric Cushing’s disease

      ea0011p743
    • Endogenous corticosteroid synthesis in subjects after bilateral adrenalectomy

      ea0011p744
    • Tissue specific regulation of insulin signalling: a mechanism of glucocorticoid induced obesity?

      ea0011p745
    • BXL-628, a vitamin D analog, decreases RhoA/ROK signalling in rat and human bladder

      ea0011p746
    • Evaluation of aldosterone to renin ratio in patients with adrenal incidentalomas and/or hypertension

      ea0011p747
    • Prenatal diagnosis of the “low-oestriol” disorders Smith-Lemli-Opitz syndrome (SLOS), oxidoreductase deficiency (ORD) and sulfatase deficienciy (STSD)

      ea0011p748
    • Hydrocortisone replacement therapy- the controversy continues…

      ea0011p749
    • Dietary polyunsaturated fatty acid supplementation in vivo modulates ovine adrenal steroidogenesis in vitro

      ea0011p750
    • Human endothelial cells (HUVECs) potentiate aldosterone secretion from human adrenocortical cells through a PKA independent pathway

      ea0011p751
    • Alterations in Scavenger Receptor B1 and steroidogenic enzymes within the adrenal gland in response to dietary bile acids

      ea0011p752
    • Salivary cortisol as an alternative to serum cortisol in 1ug ACTH test

      ea0011p753
    • Novel mutations in the ACTH receptor gene as a cause of familial glucocorticoid deficiency

      ea0011p754
    • Opposite effects of DHEA and DHEAS on chromaffin cells proliferation

      ea0011p755
    • The glucocorticoid receptor 1a promoter in CD4⁺CD8⁺ thymocytes is rapidly upregulated following dexamethasone treatment in vitro

      ea0011p756
    • 11beta-hydroxysteroid dehydrogenase is an early and essential marker of human adipogenesis

      ea0011p757
    • Mechanisms of human prolactin regulation by oestrogen

      ea0011p758
    • Dimerisation of the melanocortin-2 receptor accessory protein MRAP

      ea0011p759
    • Expression of oestrogen receptor related proteins beta occurs in multiple cell types within human endometrium during the normal menstrual cycle

      ea0011p760
    • Rapid glucocorticoid effects on insulin sensitivity

      ea0011p761
    • Differential regulation of Cyp4A isoforms in mouse kidney during the development of mineralocorticoid, salt-sensetive induced hypertension

      ea0011p762
    • Glucocorticoid receptors exert a profound anti-proliferative and anti-survival effect on human small cell lung cancer cells

      ea0011p763
    • Quantitative analysis of mifepristone (RU38486) in plasma by HPLC triple quadrupole mass spectrometry

      ea0011p764
    • NaB affect the local regulation of vitamin D in colorectal cancer

      ea0011p765
    • Bone mineral density in patients with cushing’s disease. the impact of impaired glucose homeostasis

      ea0011p766
    • Bone mineral density and its correlation with plasma cortisol concentrations in patients with inactive adrenal adenomas and in patients with subclinical and overt Cushing’s syndrome

      ea0011p767
    • Phenotypic variability in P450 oxidoreductase deficiency may be caused by differential effects of P450 oxidoreductase mutations on steroidogenesis

      ea0011p768
    • Insulin-Like Factor 3: a new circulating marker for the polycystic ovary syndrome-type of ovarian dysfunction

      ea0011p769
    • Transcriptional control of differential glucocorticoid receptor expression: determining tissue specific expression and protein isoforms

      ea0011p770
  • Thyroid
  • • In healthy women increasing tsh concentrations within the normal range are associated with increasing cardiovascular risk

      ea0011p771
    • A case of delayed diagnosis of pituitary resistance to thyroid hormone (PRTH)

      ea0011p772
    • Relationship between sodium iodine symporter and thyroid peroxidase expression and cytokines production by thyrocytes from patients with immune and non-immune thyroid disorders

      ea0011p773
    • The reference ranges of maternal thyroid hormon (thyrotropin and free thyroxin) at the second and third trimesters of pregnancy: impact of FT4 assays

      ea0011p774
    • The effect of high calcium on activity of thyroid gland in rat

      ea0011p775
    • Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to low-dose radioiodine therapy in out-patients with large non-toxic multinodular goitre

      ea0011p776
    • Clinical aspects and diagnostics of follicular thyroid tumours

      ea0011p777
    • Prevalence of thyroid dysfunction in old residents in the province of Pavia, northern Italy

      ea0011p778
    • Thyroid function in patients with atrial fibrillation

      ea0011p779
    • Hyperthyreosis treated with thyroid artery embolization

      ea0011p780
    • Psychological wellbeing correlates with free T4 but not free T3 levels in patients on ‘adequate’ thyroid hormone replacement

      ea0011p781
    • Correlation between endogenous thyroxin and A, G, and M immunoglobulins in dysthyreosis

      ea0011p782
    • Long-term results of decompression surgery in thyroid-associated ophthalmopathy

      ea0011p783
    • Fixed dose radioactive iodine therapy for hyperthyroidism: the west of Ireland experience

      ea0011p784
    • Pathogenic mutations in gene RET in patients with medullary thyroid carcinoma found in Polish population

      ea0011p785
    • Epidemiology of endemic goiter in mountain region of Adjara Autonomy Republic (Georgia)

      ea0011p786
    • Epidemiologic analysis of thyroid fine needle aspiration biopsies over a period of 18 years (1987-2004)

      ea0011p787
    • Differentiated thyroid carcinoma: experiences from a centre in south India

      ea0011p788
    • Ultrasound thyroid changes: Moscow population screening results

      ea0011p789
    • Quality of life, health status, symptoms and treatment satisfaction in subclinical hypothyroidism: a double - blind 12-week cross - over study of L-thyroxine versus placebo

      ea0011p790
    • Loss of heterozygosity and genetic association analyses within 11q13.5-q14 chromosomal region in papillary thyroid carcinoma

      ea0011p791
    • Environmental and socio-economic risk factors of thyroid cancer in olsztyn and the Warmia and Mazury region, Poland

      ea0011p792
    • Reverse Transcriptase (RT) inhibitors down regulate tumor growth, induce cell differentiation and re-establish iodine uptake in human thyroid anaplastic carcinoma in vitro and in vivo

      ea0011p793
    • The effect of block & replacement regime following radioiodine therapy for thyrotoxicosis on thyroid function in the post-radioiodine period

      ea0011p794
    • Prevalence of amiodarone-induce thyroid disorders in iodine deficiency region

      ea0011p795
    • Correction of oxidative metabolism in myocardium by oligocrine during experimental thyrotoxicosis

      ea0011p796
    • The metabolic syndrome and the thyroid in euthyroidism

      ea0011p797
    • Thyroid disease prevalence and incidence in a Dutch population survey

      ea0011p798
    • Increased lipid peroxidation in critically ill patients with low-T₃ syndrome

      ea0011p799
    • Asymmetric dimethyl arginine levels in thyroid diseases

      ea0011p800
    • Results of fine-needle aspiration biopsy of thyroid nodules in region of mild iodine deficiency

      ea0011p801
    • Thyroid cancer: diagnostic role of ultrasound and ultrasound-guided fine needle aspiration biopsy (US-FNAB) evaluation

      ea0011p802
    • Parathyroid hormone determination in fine needle aspirates (PTH-FNAB) allows the differentiation between thyroid and parathyroid lesions

      ea0011p803
    • Heart rate variability in thyroidectomized patients using suppressive therapy with thyroxine

      ea0011p804
    • Clinical value of the assessment of neopterin in Graves’ ophthalmopathy

      ea0011p805
    • Maternal iodine deficiency alters learning ability and emotional state of the progeny

      ea0011p806
    • Quantitative and qualitative evaluation of the impact of a ten-year iodine intervention programme in rural areas of Tehran

      ea0011p807
    • Effect of oral administration of propylthiouracil during pregnancy and lactation period on isolated aorta response of their adult male off springs

      ea0011p808
    • Study of the prevalence and mechanisms of action of TSH receptor and Gs protein alfa-subunit mutations, in toxic multinodular goiter and toxic adenoma from Galicia (Spain)

      ea0011p809
    • The relationship between echocardiographic left atrial size and atrial fibrillation in patients with Graves’ disease

      ea0011p810
    • ClC-5 does not affect megalin expression and function in the thyroid gland

      ea0011p811
    • Rap (LDL receptor-associated protein) expression in thyroid epithelial cells: evidence for tsh-dependence in vivo and in vitro

      ea0011p812
    • Liver enzymes alterations during high dose intravenous glucocorticoid pulse therapy for graves’ ophthalmopathy: frequency and putative risk factors

      ea0011p813
    • High-intensity focused ultrasound (HIFU) treatment for thyroid nodules: first clinical study

      ea0011p814
    • Digital infra-red orbital thermography in the assessment of thyroid eye disease

      ea0011p815
    • Prognostic factors for persistent or recurrent disease from a series of 81 patients with oncocytic thyroid carcinoma

      ea0011p816
    • Association of CTLA-4 exon 1 polymorphism with Graves’ disease in Spanish patients

      ea0011p817
    • Reference intervals of maternal free thyroxine (FT4) at the second and third trimesters of pregnancy using the Beckman Coulter’s Access^® free T4 assay

      ea0011p818
    • Bioavailability of iodine bound in humic substances in drinking water and the impact on thyroid function

      ea0011p819
    • Application of positron emission tomography (PET) in the study of cerebral glucose uptake in hypothyroid rats: effect of T3 administration

      ea0011p820
    • The development of a symptom-based clinical activity score for thyroid eye disease

      ea0011p821
    • A qualitative study of patients’ experience of thyroid eye disease

      ea0011p822
    • Etiology of congenital hypothyroidism in children with a normal located thyroid gland

      ea0011p823
    • Clinical characterisation and genetic analysis of a large euthyroid family with TSH-receptor germline mutation (N372T) and a hyperthyroid index patient with an additional somatic tsh-receptor mutation (S281N) on the second TSH-receptor allele

      ea0011p824
    • Estimation of the optimal diagnostic complex of the treatment of the nodular euthyroid formations of thyroid

      ea0011p825
    • The diagnostic value of doppler ultrasonography in determining the malignancy potential of thyroid nodules

      ea0011p826
    • Favourable outcome of Graves’ ophthalmopathy (GO) after glucocorticoids (GC) in patients treated with total thyroid ablation (TTA): results of a randomized clinical trial

      ea0011p827
    • Lipids profile and carotid scan atherosclerotic parametres in newly diagnosed hypothyroid females

      ea0011p828
    • Safety of pharmacological treatment of thyroid diseases during pregnancy

      ea0011p829
    • Increase of L-thyroxine requirement during pregnancy

      ea0011p830
    • Congenital thyroid hemiagenesis in associaton with multinodular goitre: a case report

      ea0011p831
    • Insulin-like growth factor-1 counteracts ¹³¹I-induced thyroid stunning by stimulating the transcription of the sodium/iodide symporter (NIS)

      ea0011p832
    • A case of Riedel’s thyroiditis successfully treated with glucocorticoids

      ea0011p833
    • An audit of radioiodine treatment for thyrotoxicosis in Cambridge

      ea0011p834
    • On-levothyroxine measurement of thyroglobulin is not a reliable screening test for patients at high risk of remnant/recurrent differentiated thyroid carcinoma

      ea0011p835
    • Prevalence of somatic TSHR and GS alpha mutations in toxic thyroid nodules (TTNS) in endemic and nonendemic goiter areas of turkey

      ea0011p836
    • The role of autoimmunity and thyroid function on pregnancy outcomes in euthyroid women with autoimmune disease undergoing assisted reproduction

      ea0011p837
    • Value of routine measurement of serum calcitonin concentrations in patients with nodular goiter: a multicenter study

      ea0011p838
    • Association between patient- and tumor-related factors and the gene expression profile of papillary thyroid cancer

      ea0011p839
    • Levothyroxine suppressive therapy in thyroid nodules

      ea0011p840
    • Levothyroxine suppressive therapy and body composition

      ea0011p841
    • Differential regulation of soluble Fas in patients with autoimmune thyroid disease

      ea0011p842
    • Application of new tecnology of anti-DNA antibodies detection in diagnostics of autoimmune thyrioditis

      ea0011p843
    • Thyroxine replacement dose in patients with hashimoto disease: a potential role for interleukin-6

      ea0011p844
    • The glutathione peroxidase 3 promoter is activated by Pax8

      ea0011p845
    • Similarities in the role of FoxE1 in thyrocytes and keratinocytes?

      ea0011p846
    • Inhibin B/inhibin binding protein complex is differentially expressed in normal and nodular human thyroid tissue

      ea0011p847
    • Towards the development of a valid quality of life questionnaire for patients with thyroid diseases: Which questions shall we ask?

      ea0011p848
    • The efficacy of levothyroxine therapy in the nontoxic multinodular goiter

      ea0011p849
    • Association of the FCRL3 gene with Graves’ disease in the UK Caucasian population

      ea0011p850
    • Treatment options in progressive medullary, follicular, and papillary thyroid carcinomas: Evaluation of chemotherapy with doxorubicin

      ea0011p851
    • Staging of progressive papillary, follicular, or medullary thyroid carcinomas: Comparison of various staging procedures to define the extent and progress of disease

      ea0011p852
    • The effects of orlistat and sibutramine on serum thyroid hormone levels in obese subjects

      ea0011p853
    • The research of IQ level in school children who live in the regions with iodine deficiency

      ea0011p854
    • Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients

      ea0011p855
    • Somatostatin receptor scintigraphy with 99mTc-HYNIC-TATE in visualization of non-radioiodine-avid differentiated thyroid carcinoma

      ea0011p856
    • A novel test with recombinant human TSH for the differential diagnosis of congenital hypothryoidism in pediatric age

      ea0011p857
    • The use of recombinant human thyrotropin (rhTSH) in amiodarone- induced hyperthyroidism

      ea0011p858
    • Thyrotropin receptor (TSHR) activation has variable effects on the TNFα axis in preadipocyte and osteoblast-like cell lines

      ea0011p859
    • Clinical parameters and echographic patterns are poorly predictive of malignancy in thyroid nodules with a cytological diagnosis of follicular and Hv¨rthle cell neoplasia

      ea0011p860
    • The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism

      ea0011p861
    • Comparison of the effects of thyrotropin receptor (TSHR) activation on preadipocyte cell lines from white (WAT) and brown (BAT) adipose tissue

      ea0011p862
    • Effects of increment of endogenous TSH levels on the effective half-life time of ¹³¹I and iodine uptake by thyroid remnants in patients after thyroidectomy

      ea0011p863
    • Surgery should be considered equally with I¹³¹ and thionamide treatment as first line therapy for thyrotoxicosis

      ea0011p864
    • Thyrotoxicosis – a risk factor for subsequent development of osteoporosis?

      ea0011p865
    • Relationship between cardiac arrhythmias and subclinical hyperthyroidism

      ea0011p866
    • Cardiovascular disease in patients with and without hypothyroidism

      ea0011p867
    • Clinical parameters and echographic patterns are poor predictive of malignancy in follicular and Hürthle cell nodules at cytology

      ea0011p868
    • Identification of housekeeping genes useful for the normalization of rna in studies of gene expression in thyroid carcinomas

      ea0011p869
    • Identification of a novel germ-line point mutation of the ret gene (Met848Thr) in a patient affected by medullary thyroid carcinoma and castleman’s syndrome

      ea0011p870
    • Usefulness of molecular analysis of BRAF mutation and RET/PTC rearrangements in fine needle aspiration (FNA) of thyroid nodules with nondiagnostic cytology

      ea0011p871
    • Does Selenium deficit trigger post partum thyroditis

      ea0011p872
    • 17-AAG and DIDS increase the iodide retention time in thyroid cancer cells transfected with NIS

      ea0011p873
    • Demethylating treatment with azacytidine induces retinoic acid receptor RAR beta expression in human thyroid cancer cells

      ea0011p874
    • Free thyroxine (FT4) is the analyte of choice in early gestation

      ea0011p875
    • Comparison of TPOAb assays in early pregnancy

      ea0011p876
    • Age and gender differences and phenotypes of patients with autoimmune thyroid disease – The UK AITD consortium

      ea0011p877
    • Influence of family history on the age of presentation of AITD – the UK AITD consortium

      ea0011p878
    • Prevalence thyroid dysfunction and other autoimmune disorders within the families of subjects with autoimmune thyroid disease – the UK AITD consortium

      ea0011p879
    • Do SNPs within the PTPN22 gene contribute to autoimmune disease via different mechanisms?

      ea0011p880
    • Screening of autoimmune thyroid disorders in pregnancy in a highland district

      ea0011p881
    • Gene expression profile in functioning and non-functioning nodules of autonomous multinodular goiters from an area of iodine deficiency

      ea0011p882
    • Comparison of efficiency of iodine-profilaxis in helthy pregnant women and pregnant women with non toxic goiter, living in region with mild iodine-defficiency

      ea0011p883
    • Gene expression profile in orbital fibroblasts from a tao patient before and after adipocytic differentiation

      ea0011p884
    • Is subclinical hyperthyroidism associated with blood pressure and hypertension?

      ea0011p885
    • Thyrotoxicosis in Childhood: UK and Ireland Surveillance Study 2004–2005

      ea0011p886
    • PKA II mediates cAMP-dependent phosphorylation of CREB and activation of gene transcription in differentiated rat thyroid cells

      ea0011p887
    • Transcriptomic analysis of the oncocytic signal in vesicular thyroid tumours

      ea0011p888
    • Application of MRI in the differential diagnosis of different forms of Hashimoto’s thyroiditis in patients from the iodine deficient region

      ea0011p889
    • Immunohistochemical staining for thyroid peroxidase (TPO) of tru-cut biopsies from scintigraphically cold thyroid nodules

      ea0011p890
    • Regulation of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone (T3): identification of a thyroid hormone response element (TRE) in the murine Fgfr1 promoter

      ea0011p891
    • Subclinical hypothyroidism – how soon to treat?

      ea0011p892
    • Cytostatic effect of plitidepsin (AplidinTM) in human undifferentiated (anaplastic) thyroid carcinoma

      ea0011p893
    • A case of severe thyrotoxic hypercalcaemia

      ea0011p894
    • Efficacy of high dose radioiodine in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole body iodine scan

      ea0011p895
    • Isometric tension studies in a transgenic mouse model of thyroid hormone resistance

      ea0011p896
    • The GH response to ghrelin in humans is reduced in conditions of hyper- and hypothyroidism

      ea0011p897
    • Multicenter evaluation of the Abbott ARCHITECT^® anti-Tg and anti-TPO assays

      ea0011p898
    • Autoantibody profile in patients with Graves’ disease and thyroid-associated ophthalmopathy

      ea0011p899
    • Treatment of disseminated non-radioiodine - avid papillary thyroid cancer with ⁹⁰Y-DOTA-TATE preparation

      ea0011p900
    • Hashimoto’s thyroiditis in the children: clinical features at presentation

      ea0011p901
    • Corticotherapy alone or corticotherapy combined with orbital radiotherapy in severe active Graves’ ophthalmopathy: therapeutic outcome in 905 patients

      ea0011p902
    • The effects of treatment with L-thyroxin on level of prolactin, CRP and insulin in premenopausal women with subclinical hypothyroidism

      ea0011p903
    • Modifications in the frequency of presentation and the TNM stage at diagnosis of thyroid carcinoma in the last decade in Valencia (Spain)

      ea0011p904
    • Pretreatment with rhTSH allows effective ¹³¹I therapy in patients with multinodular toxic goiter and low radioiodine uptake

      ea0011p905
    • Repression of the human NIS upstream enhancer (hNUE) by PTTG

      ea0011p906
    • Comparison of cytogenetic damage in patients with differentiated thyroid cancer receiving ablative ¹³¹I therapy in the hypothyroid status versus the euthyroid status (rhTSH assisted treatment)

      ea0011p907
    • Correction of hypomagnesaemia improves the symptoms of hypocalcaemia after thyroidectomy

      ea0011p908
    • The thyroid gland and its selenoenzymes are preferentially supplied in selenium-deficient transgenic mice

      ea0011p909
    • Changes in thyroxine requirement in the long-term follow-up of hypothyroid patients

      ea0011p910
    • Problems of identifying independent non-class II susceptibility loci within the HLA region for Graves’ disease

      ea0011p911
    • Is ¹³¹I therapy for hyperthyroidism harmful for testis function?

      ea0011p912
    • What is the most effective screening interval in the long-term follow-up of stable hypothyroid patients on thyroxine?

      ea0011p913
    • Expression and signal transduction of the cAMP-binding protein Epac in thyroid cells and thyroid tumors

      ea0011p914
    • Orbital tissue expansion expressed as a number: usefulness in grading the severity of thyroid-associated ophthalmopathy (TAO)

      ea0011p915
    • Radioiodine treatment for hyperthyroidism – do royal college guidelines suggest too high a radioiodine dose?

      ea0011p916
    • Thyroid cancer management: are guidelines being met?

      ea0011p917
    • Treatment of patients with Graves’ disease and ophthalmopathy with the anti-CD20 monoclonal antibody rituximab

      ea0011p918
    • Withdrawal of alfacalcidol supplements following thyroidectomy: baseline plasma PTH predicts successful outcome

      ea0011p919
    • Treatment of pretibial myxdedema with dexametazone injected subcutaneoulsy by mesotherapy needles

      ea0011p920
    • Radioiodine uptake test reduces duration of restrictions following radioiodine therapy for management of hyperthyroidism

      ea0011p921
    • The distance between histotypes of differentiated thyroid cancer: gene expression profiling study

      ea0011p922
    • The risk of hypercholesterolemia in patients with subclinical hypothyroidism

      ea0011p923
    • Audit of management of hypothyroidism in a joint endocrine/antenatal clinic

      ea0011p924
    • Thyrotoxicosis is coupled with quantitative and qualitative sleep disruptions

      ea0011p925
    • The Gods placed the diagnosis before the therapy: case reports of the Slovak families with resistance to thyroid hormones

      ea0011p926
    • Epidemiology of thyroid cancer in Republic of Sakha during 1970–2001

      ea0011p927
    • Rate of decrease in antithyroid antibody levels after therapeutic intervention in patients with thyroid cancer

      ea0011p928
    • Futher results of treatment and outcomes in patients with subacute thyroiditis observed in the period from 1993 to 2005

      ea0011p929
    • Cowden syndrome - a clinical entity to be aware of

      ea0011p930
    • Fine-needle aspiration biopsy of thyroid nodules

      ea0011p931
    • Palpation versus ultrasonography-guided fine-needle aspiration biopsy of thyroid nodules in endemic goiter area

      ea0011p932
    • Thyroid storm induced cardiomyopathy is reversible

      ea0011p933
    • Medullary thyroid carcinoma – which test is the best?

      ea0011p934
    • Glutamic acid decarboxylase (GAD) and anti-tyrosine phosphatase (IA2) antibody positivity in newly-diagnosed Graves’ disease patients

      ea0011p935
    • Hyperthyroidism presenting as ventricular fibrillation

      ea0011p936
    • Heart rate dynamics in hyperthyroidism

      ea0011p937
    • Impact of TNM classification categories on thyroid gland carcinoma

      ea0011p938
    • Antiproliferative effects of SOM230 on orbital fibroblasts from active Graves’ ophthalmophaty

      ea0011p939
    • Further results of treatment and outcomes in patients with subacute thyroiditis observed in the period from 1993 to 2005

      ea0011p940
    • Age related changes of soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases

      ea0011p941
    • Comparison of radioiodine with radioiodine plus lithium in the treatment of hyperthyroidism

      ea0011p942
    • Monitoring of goiter and urinary iodine excretion in 6–10 year old school children in Ahvaz (2003–2004)

      ea0011p943
    • Prevalence of subclinical dysfunctions of thyroid gland in women older than 40 years

      ea0011p944